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ABSlRCf
Ths thesis investigates the role of B cells as antigen-specific antigen-presentig
cells (APC) in self tolerance to low concentrtions of soluble self proteins and in acqui
tolerace to low doses of soluble foreign protein antigens. Experents were peronned in
norm and B cell-deficient anims, and tolerance inducton was measur by T cell
prolieration assays. T cell prliferation was reuced in B cell-deficient mice, indicatig
that B cells may be involved in effcient activation of naive T cells in response to protein
antigen both in vivo and in vitro. To study acquired tolerance induced by low doses of
soluble foreign protein antigen, norm and B cell-deficient adult mice wer injected
intrvenously with repeate low doses (10 Jlg) of deaggregated ovalbumin (OVA), and
then challenged with OVA in complete Freund' s adjuvant In anmas trated with
deaggregated OVA, the in vitro proliferative responses of LN T cells to OV A were
significantly reduced, and production of the Thl cytokine, IF-y, in response to OVA was
lost This occur in both norm and B cell-deficient trated anmas, indicatig that 
cell antigen presentation was not requir for this phenomenon. B cells were also
unnecssa for self tolerace of T cells to the trsgenic self antigen, hen egg lysozye
(H), in a transgenic mouse strn with very low serum lysozyme concentrtion. Paral
low zone tolerce induced by deaggrgated low-dose OV A was selective for the Th I
response, as measured by in vitro proliferation and IL-2 and IF-yproduction, beause
antiboy responses of nonnal mice to ths T cell-dependent antigen were largely unafecte.
Both trated and untrte anals prouced equivalent titer of anti-OVA antiboes,
preominantly of the IgG I and IgG2b isotyes, following chalenge with OVA in complete
Freund' s adjuvant Tolerace to low levels of the transgenic HE self protein in mice
expressing different MHC molecules was also addrssed. Transgenic mice that were H-
2b/ in the class n region were not tolerant to the trsgenic self protein, whereas trsgenic
mice of the H-2b1 were tolerat.
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IN1RODUCTON
Imunity against infectious agents is the result of two tyes of host responses: the
innate imune response and the adaptive or acquired immune response. The host s fist
lie of defense agaist infecton is the innate imune response. The adaptive immune
response reuis severa days to become fully activated and is the second line of defense.
Innate immunity is present from birh and is usualy a non-specific defense agaist
infection. It is composed of natu killer cells and also phagocytc cells, including
macphages and neutrophils, that can ingest and destry extrcellular micrrgansms.
Phagocytes are also able to recrt other cells of the imune response to the site of infection
by initiatig inflamtion. The proteins of the complement cascade provide furer
protection agaist infection by bindig dictly to the surace of some microorganisms
tageting them for uptae by phagocytes or for lysis.
The adptive imune response is initiated only when the infection canot be
controlled by the innate immune response. Unlie innate imunity, which is present at 
ties, the adptive imune response arses only afer encounter with the infectious agent
and is speifc for the infecting organism. Adaptive immunity also provides the host with
imunological memory in the event that the sae pathogen initiates a second inection.
The adptive imune response can be divided into antiboy-medated and cell-medated
immunity depending on whether B lymphocytes or T lymphocytes are responsible for
providig protection agaist the infectious agent
Several components of the innate imune response work in conjunction with the
components of the adaptive immune response to combat infection. The reeptors and
response mechanisms of the innate immune system used to detect infectious agents can
intiate the adptive imune respnse; for example, in response to intrcellular bacteria, an
inecte macrphage wil present antigen to T cells. The intrellular bacteria provide both
the peptides for presentation and induce costiulatory molecules on the macrphage,
ensurg tht the adptive imune response wil be prouctive. In addition, IF-
production by T cells enhaces macphage kiing of intracellular bactera, demonstrtig
how the adaptive imune response can also act to mae varous innate effector systems
more effcient
One of the most importt featues of the adaptive imune response is the abilty of
lymphocytes to recognize and respond to any foreign substace while raely responding
against self antigens. As discussed below, there ar severa check points that have been
clearly identified durg lymphocyte development, activation, and surval to ensur that B
and T lymphocytes do not respond to self antigens. Other potential mechansms for
mantaing tolerace to self proteins are less well defined. The work presented in this
thesis wil adss the role of the antigen-presentig B cell in periphera T cell tolerace
induction to self proteins as well as to foreign proteins.
A. Recognition of Antigen by Band T Lymphocytes
The adptive imune response is initiate when the receptors on lymphocytes
reognze antigen. Lymphocytes contiuously recirculate from the bloostram thugh the
periphera lymphoid organs, such as the lymph node (LN), spleen, and gut-associated
tissues, where they encounter any number of different antigens. How does the boy
detenne which lymphocyts wi respond to an antigen? The clonal selection theory
proposes that a pre-existig population of lymphocytes with the potential to respond to an
antigen, ar the only cells selecte to respond (1). B lymphocytes and T lymphocytes each
have highly varable antigen receptors which ar monospecific; thus one cell expresses a
reeptor that can reognze only one antigen. Cells speifc for self antigens ar removed
durng lymphocyte development and for the most pan ar absent from the pephera pol
of respondig lymphocytes. When matu lymphocytes come in contat with an antigen
they regnize, they beme activate and proliferate. Thus each cell spefic for 
antigen can give rise to a clone of identical progeny with the same antigen specifcity.
These clones then develop into effector cells that can eliate the antigen. Once the
antigen is clear, the immune response is then downegulated. Some of the activated cells
wi have diferentiated into memory cells that can respond more rapidly upon a second
encounter with same antigen, providig protection or imunity against the original antigen.
Since B and T lymphocytes ar involved in diferent effector functions in the
imune response, it is not surrising that their antigen receptors recognize antigen in
different ways. The B cell antigen receptor is a cell-surace immunoglobulin molecule
capable of recognzing antigen diectly, and it has the same specificity as the antiboy
molecules seted by clonal progeny following activation. Immunoglobulin molecules are
composed of two heavy chains and two light chains (2). Each of these chains contas a
varable region responsible for antigen recognition, which is encoded by varable (V),
joinig (1), and/or diversity (D) gene segments (3), and a constat region. The constat
region of the heavy chain is responsible for engaging the effector functions of the immune
system when the antiboy molecule is seceted, and detennnes imunoglobulin class.
The sam varable region gene can be spliced to one of five heavy chai constat genes, Jl,
, y, a, and E (4) in a process referred to as class or isotype switching. Isotye switching
alows antiboes with the same antigenic specificity to serve different functions in the
imune system as specifed by the constat region, such as Fc receptor bindig and
complement fixation.
The T cell receptor (TCR) is a heteromer composed of two chains, ex and , or y
and (5). Each chain of the TCR also has constat and varable regions, encoded by V, J,
and/or D-lie elements, which are joined together by gene reargement (5). However,
une the B cell reeptor, the TCR canot reognie antigen ditly. The TCR reognzes
peptide frgments of antigen bound to a cell-surace molecule encoded in the major
histocompatibilty complex (MC) (6-8). This phenomenon is referred to as MHC
restrction. The MHC molecules must be able to bind a varety of proteins derived frm
may different pathogens; therefore there are sevefa MHC genes with dierent specificities
for bindig peptide, and there are multiple alleles at each gene locus (9). Antigen
proessing is the mechanism that cells use to degre proteins into peptides for presentation
in MHC molecules to T cells (10). MHC class I molecules ar displayed on all cells
thughout the boy, and they present peptides derived from intrcellular proteins: self
proteins, proteins frm intrcellular bactera, or in the case of vir infection, viy-
encoed proteins (11). Class II MHC molecules present peptide antigens derived from
exogenous proteins and ar only found on antigen presentig cells, which include dendrtic
cells, macrophages, and B cells (10). The TCR expresses one of two MHC-specific co-
reeptor molecules, CD or CD8, that enhance the abilty of T cells to engage either class n
MHC molecules or class I MHC molecules, respectively (12). CD8+ T cells and CD4+ T
cells serve diferent functions in the immune response. CD8+ T cells, referr to 
cytotoxic T cells, ar able to kill inected cells exprssing MHC class I molecules
presenting foreign peptides. The CD4+ cells provide help for cell-medated and antiboy-
medated responses and can be divided into two helper subsets, Th1 and Th2, based on the
patter of cytokines they secte (13).
Lymphocyte Development
Lymphocytes develop in the centr lymphoid organs, either the bone marw or the
thymus. Al lymphocytes originate from stem cell precursors in the bone marw. Stem
cells exit the bone maw and migrte to the thymus for development into T cells, whereas
B lymphocytes rema in the bone marow for the maturation process. As lymphocytes
matu and begi to exprss their antigen reeptors, the cells with reeptors that recognze
self antigens are either deleted or inactivated. The eliation of these self reactive B and T
cells durg development is refered to as centr tolerace induction or clonal deletion.
The stages of B cell development can be marked by imunoglobulin gene
reargements (14). Initialy, both the heavy and light chain genes ar in the gennne
confgution, but as the stem cell preurr proees into the early pro-B cell stage, the
heavy chai genes, D and J, are rearanged. Next, the varable region of the heavy chain is
joined to the DJ segment formg the late pro B cell. As pro- B cells mature into pre- B
cells, intat Jl heavy chais are expressed in the cytoplasm and also at low levels on the cell
surace, and the V and J light chain genes sta rearging. The imtu B cell is
prouced when the light chai genes are reaanged and the cell expresses both light and Jl
heavy chains on the surace as IgM molecules. The fmal stage of B cell development is
complete when the immature B cells express both cell-surace IgM and IgD, due to
alternative RNA prssing and choice of trscrption termnation sites in the heavy-chai
transcpts (15). These matu B cells then exit the bone maw and cirulate in the
periphery. B cell precurrs cannot progrss beyond the early pre- B cell stage if the Jl
heavy chain is not expressed on the cell membrane, as shown in B cell-deficient animals
crte by the tageted disruption of the trsmembre region of the Jl heavy chain (16).
In ths thesis, I took advantage of these mice to exame T cell tolerace induction in the
absence of B cells.
The eliation of self-reactive B cells ocur at the immtu B cell stage when the
newly for reeptor has just ben expressed on the cell-surace. If these IgM molecules
ar able to bind to multivalent cell-surace selfligands in the bone marw, then these cells
ar eliated by progred cell death or apoptosis. This was demonstrte by Nemazee
and Btiki using trsgenic mice expressing immunoglobulin molecules speifc for H-
and D class I MHC molecules of the k-haploty (17). When these mice were mataed
on the H- backgrund, the anti-MHC-specific B cells could be found as responsive cells
in the periphery. However, when the trsgene was expressed in H-2k/d mice, and when
the H- self antigen was expressed on the cell-surace of other cells in the bone marw,
the anti-MHC-specifc B cells could no longer be detected.
In contrst, immatu B cells with IgM molecules specifc for soluble self antigen
ar not elimated but instead can be rendere anergic or unrsponsive to the self antigen.
Anergic cells persist in the peripher, but are unable to expand in response to antigen. This
was shown in experiments perfonned by Gooow and colleagues using double-trsgenic
mice expressing both the soluble trsgene-encoded self antigen HEL and the B cell
reeptor specifc for HEL (18). The numbe of HEL-specifc B cells was not reuced in
these mice, as compar to mice caring only the single imunoglobulin HEL transgene,
indicatig that the autorective B cells were able to escape clonal deletion in the presence of
their self antigen HE (18). However, the HEL-specifc B cells frm the double transgenic
mice had reuced levels of cell-surace IgM, but not IgD, and were unable to produce anti-
HE antiboy (18).
As thymocs migrte though the thymus, they also express dierent cell-surace
molecules durng matuation (19). Initially, they do not express the TCR, CD3, or either
of the co-reeptors, CD4 or CD8, and ar referr to as double negative cells (20, 21).
Then gene reangement occur and low levels of the T cell receptor ex and chains 
expresse along with both co-reeptor molecules, CD4 and CD8, producing double
positive cells (20, 21). It is at this point that thymocytes are screned for their abilty to
reognze self MHC molecules, and for whether they wil react to self peptides presente
on self MHC. These two events have ben termed positive and negative selection,
respectively.
Positive selection occur when thymocytes encounter thymic stroma cells
expressing self MHC. Thymocytes with TCRs that bind self MHC are signaled to continue
their matution, whereas thymocytes that do not recognize self MHC undergo
progred cell death. Classic experients peronned in bone maw chimeric mice
demonstrte that bone tnOW cells injecte into irdiated alogeneic or semialogeneic
hosts develope into T cells that "leaed" to recognize antigen only on the MHC molecules
expressed on the raoresistat thymc epithelial of the iradated host (22 23). The arval
of trsgenic tehnology faciltated the dit demonstrtion of positive selection.
Thymytes bearg a trsgenic TCR only developed into matu perpher T cells when
they could reognize the MHC molecules that were presenting peptide in the thymus (24-
26). When these cells were unable to recognize the MHC molecules in the thymus, they
died at the CD+CD8+ stage of development. The percentage of CD4 and CD8 cells found
in the perphery of the transgenic animals was also influenced by the expression of the
trsgenic TCR. TCR reogntion of peptides on class I resulted in a predomiance of
peripher CD8+ T cells, wheres a higher percentage of CD4+ T cells resulted from peptide
reogntion on class II MHC. These experiments demonstrated that the TCR, MHC, and
CD4 or CD8 molecules were all involved in the press of positive selection.
The positive selection proess pets surval of T cells with TCRs capable of
reognizng foreign peptide on self MHC, as well as those recognizng self peptide on self
MHC. The negative selection proess, medated by thymc macrophages and dendrtic
cells, effectively elimiates thymocytes with T cell receptors that bind with high afity 
self antigen in assoiation with self MHC. Deletion of autoreactive thymoytes was fit
demonstrte in the laboratory of John Kappler using an antiboy that detects V1317a+ T
cells, which react with an endogenous superantigen plus the MHC class II protein I-E, to
show that these cells were present in the thymus but not in the perphery of mice expressing
the I-E MHC molecule (27). Dit demonstrtion of negative selection was also shown
using trsgenic mice. Kisielow and colleagues found deletion of TCR transgenic T cells
in mae mice that expressed a recptor spefic for the male (H- Y) antigen restrcted to class
I H- MHC molecules (28). In other experients, thymic presentation of the transgenic
self antigen, OVA, following Lp. injecon, resulte in the deletion of OVA-speifc TCR
trsgenic CD4+CD81'CR thymytes by apoptosis (29).
Both positive and negative selection reuir T cell recognition of peptide presented
on MHC molecules. How these two selection events dier is a very active ara of researh
and at least thee possibilties have been put forward: an affInity model, an altered ligand
moel, and an avidity model. The idea behind the affinity model is that high affiity
interations between the TCR and a peptide/C complex result in negative selection,
whie positive selection is the result of low afnity bindig between the TCR and self MHC
(30). The altere ligand hypthesis suggests that the positively selectig thymc stromal
cells present a unique set of peptides, whereas the bone marw cells responsible for
negative selection present peptides that are representative of those found in the periphery.
This hypthesis appear to be unlikely for two reasons: recent analysis of peptides elute
frm thymc MHC molecules does not indicate that unique peptides are presented by
corca epithelium (31), and a varety of other cell tys expressing MHC molecules, such
as fibrblats or lymphoid cells, are able to induce positive selection (32, 33). Lastly, the
dierential avidity model proposes that positive selection is a low avidity interaction,
resulting frm high affiity/low density or low afnity/high density interactions between
the TCR and peptideIMC complexes. Negative selecon is a high avidity interaction,
resulting frm high afity/hgh density interactions or aggrgation of the TCR upon
peptide/MC reognition. This model suggests that peptide presented above a given
thshold wil induce some physiological change in the TCR and will deliver an incomplete
actvation signal, which is suffcient to induce positive selection but inadequate to trgger
apoptosis and negative selection (34, 35).
When the selection process is complete, TCR expression is upregulated and,
depending on the specifcity of the TCR, the expression of either CD4 or CD8 is
downguate. These matu single positive T cells then exit the thymus. Unfortunately,
T cell selection in the thymus canot elimiate ever self-rective T cell, beause some self
peptides may not reach the theshold of presentation that ensures tolerce induction of the
developing T cells (36, 37), and other self antigens may not be presented in the thymus
durg the selection proess. Therefore, inactivation of matu self-reactive T cells must
also occur in the periphery for self antigens that ar developmentay regulated or for self
antigens that can only be found outside of the thymus. Before adssing the potential
mehanisms of periphera tolerace, it is importt to understad how mature lymphocytes
beome activated by antigen.
/ C. Lymphocyte Activation
B cells beme actvate when they regnze and bind multivalent antigen in the
pephery. Some antigens ar able to activate B cells ditly, and they ar referr to 
thymus-independent antigens or TI antigens. There are two tys of TI antigens:
polyclonal B cell activators which at high concentrtions activate both imatu and matu
B cells, regardless of their specifcity; and antigens that activate only 
matur B cells by
extensive crsslinng of the cell-surace imunoglobuli molecules, due to their highly
repetitive strctus, such as bacterial cell wal polysacchardes (38). Thymus-dependent
or 1D antigens reuire T cell help to activate the B cells. Protein antigens are bound by B
cell surace immunoglobulin molecules, interalized, processed and then presented to
helper T cells as peptides on class n MHC molecules (39). T helper cells speific for these
peptides provide help for B cell antiboy production in two ways: through the interaction of
the cell-surace molecules CD40 ligand and CD0 expressed on T and B cells, respectively,
and frm T cell cytokie secetion (40). These two signals induce B cell proliferation and
promote B cell dierentiation into antiboy-secretig cells.
T cells requie two distinct signals frm APCs to beome fully activated (41, 42).
The fist signal is thugh the TCR upon recognition of antigen in the context of self MHC
molecules. The second signal is referred to as costimulation, and it includes locally actig
soluble cytokines, such as IL- 1 and IL-6 (43), and cell-surace molecules found on
professional antigen presentig cells, lie the B7 molecules, that bind to the cell-surace
molecule CD28 on T cells (44). Dendrtic cells, macrphages, and B cells can all function
as professional APCs, although macrphages and B cells nee to be activate by antigen
fit before they wil express the appropriate costimulatory molecules. Signal one, antigen
reogntion, in the absence of signal two, costimulation, results in inactivation or anergy of
matu T cells (45). Anergy is one potential way of inducing peripher tolerace to self
antigens and will be discusse more thorughly in the next section.
Since costiulation is crtical for successful T cell actvation, it is an ara of intense
researh. Recently, our understading of T cell costimulation has become more complex
with the discovery that there are two B7 famy members found on APCs, B7- 1 and B7-
capable of binding the counter-receptors, CD28 and CT- , expressed on the surace 
Tcells. The kietics of expression of each of these molecules is unique, suggestig their
expression may correlate with different roles in the induction, amplification, and
downrgulation of the immune response. For example, both B7- 1 and B7-2 molecules 
capable of inducing T cell prolieration and IL-2 prouction, but B7-2 is constitutively
expresse (46), suggestig it may parcipate in the initiation of the immune response.
Although B7- 1 expression can be found constitutively on some APC, on others it appear
48 hour after activation (47), indicating that it may serve to amplify or regulate the imune
response.
The counter-receptors are also expressed diferentialy. CD28 is constitutively
expressed at high levels on al mouse T cells, wherea CT-4 expression cannot be
detete unti 2-3 days after T cell activation. The contrbution of each of the costiulatory
molecules in T cell activation has ben furer elucidated by the cration of mice deficient 
one or more of these molecules. Examning the T cell responses of CD28 deficient anmas
has indicate that the major B7-binding costiulatory ligand on T cells is CD28 (48, 49).
A negative regulatory role for CT-4 was initialy suggested from experiments showig
that crss-linng CTA-4 on activatedT cells would result in antigen-specifc apoptosis
(50). CT-4 has ben diectly implicated in the downgulation of T cell activation,
beause CT-4 deficient mice have massive lymphoprolierative disorder and die at the
weeks of age (51 , 52).
The AP plays a pivota role in T cell activation, because, as mentioned above, if it
does not prvide the proper costiulatory signals, the T cell will be inactivate Each 
of APC, dendrtic cells, macrphages, and B cells, not only vares in their expression of
the B7 molecules, but has dierent roles in the imune response. Dendrtic cells have
ben implicate in initiatig T cell responses, beause they constitutively express the
costimulator molecules B7-1 and B7-2 and also have high levels of class I and class II
MHC molecules on their cell surace (53). These propertes, in addition to their expression
of the adesion molecules ICAM- , ICAM-3, and LFA-3, make them potent stiulators of
naive T cells. It has been suggeste that the role of the dendrtic cells of the ski, epidennal
Lagerhans cells, in the imune response is to brig antigen from the site of infection to
the lymphoid tissues. Lagerhans cells, unlie matu dendrtic cells, are able to pick 
and proess antigen efficiently, and following infection they migrte to the LN, where they
then differentiate into dendrtic cells. Recently, it has been shown that Langerhans cells,
previously thought to be negative for costimulatory molecule expression, have B7-2 on
their cell surace (54).
The higWy phagocytc maCfophages are the scavenger cells of the immune system.
They ar an importt par of the innate imune response, since they express Fc and
complement reeptors, alowing them to engulf opsonized paricles. They also possess
reeptors for micrbial constituents, such as the macphage manose receptor and
reeptors for lipopolysaccharde, a component of the cell wals of Gra negative bactera
(55). Restig maCfophages or monocytes do not express the costimulatory molecule B7-
but they do express B7-2, and they have low levels of class II MHC molecules on their cell
surace. Macrphages upregulate the expression of B7 -1 and MHC class II when they
engulf micrrganisms or ar stiulated though other receptors. Therefore, they can
contrbute to the adptive immune response by activatig naive T cells (56).
B cells not only contrbute to the adaptive immune response by the prouction of
antiboy, but they ar also very effcient APC for specific antigens because of their cell
surace imunoglobulin reeptors. They can pick up 1O,OO-fold lower concentrtions of
soluble antigen than other non-speifc antigen presenting cells (39, 57). Restig B cells,
although they constititutively express high levels of class II MHC molecules, ar unable to
acvate naive T cells beause they do not express either of the costiulatory B7 molecules.
However, B7- 1 and B7-2 expression can be induced on B cells by crosslinkng their
imunoglobulin antigen receptor, or by stiulation with the microbial component
lipopolysaccharde (58), or by CD40L or cytokines.
When naive T cells become activated followig antigen recogntion on a
professional APC, they proliferate, secrte their autocne grwth factor IL-2, and express
the high affiity IL-2 receptor (59). The incrased prouction of IL-2 is the diect result of
the costiulator signal derved frm the AP, as the ligation of the CD28 molecule on the
T cell both increases the trscrption of IL-2 mRA and stabilzes IL-2 mRA (60, 61).
The prouction of IL-2 allows T cells specifc for the peptide antigen on the APs to
expand and differentiate into effector populations. Ther ar at least thee possible T cell
effector populations each having diferent functions in the imune response: class I MHC-
restrcted cytotoxic CD8+ T cells, and two subsets of CD4+ class II MHC-restrcted T
helper cells, Th1 and Th2. It has been suggested that Th1 and Th cells arse frm a
commn preuror cell referr to as the ThO cell. Restig naive CD4+ T cells develop into
a plurpotential ThO cell upon priar stiulation with a specific antigen. ThO cells secrte
lymphokies characterstic of both matu T helper subsets. Th1 cells secete the cytokies
IL-2, IF-y, and lymphotoxin, whereas Th2 cells secrete IL- , IL-5, IL-6, and IL- IO (62).
The cytokies sected by Th 1 cells activate macrophages, medate delayed tye
hyprsensitivity reactions, and provide some help for B cells, with IFy promoting IgG2a
antiboy prouction. Th cytokies ar involved primaly with B cell help, as IL-
promotes IgG 1 and IgE antiboy formtion. IL-4 also has ben implicated in the
suppression ofTh1 responses. Th1 and Th cells secete mutually inhibitory cytokies,
which crss reguate each other (63). Therefore, the development ofTh1 or Th effector
cells detennnes whether the resulting immune response wil be cell-medate or antiboy-
medated, respetively (64). In this thesis, I show that repeated exposure to low
concentrtions of soluble antigen selectively inactvates the Th 1 response.
D. Peripheral Tolerance
As mentioned previously, when B cells and T cells mature, precautions 
ar taen to
ensur that lymphoctes recognizing self antigen ar eliated. Because not all self
antigens ar expresse at high levels durng the lymphocyte development, and because self
reactive B and T cells can be found in the periphery of norm heathy individuals, there
must be mehansms to mata tolerace in matur lymphocytes to self antigen
encountere in the periphery. Evidence that self-reactive cells can be uncovere in the
pephery has been shown in nonnal mice chalenged with myelin basic protein (MP).
Autoreactive T cells spefic for MBP ar not deleted durg maturtion, and following
chalenge with MBP in adjuvant they can even be activated to induce experienta alergic
encephalomyelitis (E), a moel for multiple sclerosis (65).
For autoreactive B cells there ar at least thee mechanisms to keep these cells frm
secting antiboy that recognizes self proteins. As mentioned above, for most mature B
cells to beome activated they reuir help frm T cells in the fonn of cell-surace
interactions as well as frm the cytokies produced by the helper T cell. Therefore, if the
helper T cell is unspnsive or tolerant to the perpher self antigen, the autoractive B cell
il '
wil not be prvided with the help it reuirs to proliferate and diferentiate into an
antiboy-setig cell (66). The other mechanisms for mataing B cell tolerance to self
antigens in the periphery ar the same as those found durng development. Membrae-
bound antigens cause deletion and soluble antigens induce anergy or inactvation. Russell
and colleagues demonstrted peripher deletion of autoreactive B cells in a double-
transgenic moel; anti- immunoglobuli transgenic B cells were present in the bone
maw but were deleted in the periphery due to liver expression of the MHC class I
antigen K (67). However, Goonow and colleagues found when B cells encounter high
concentrations of soluble self antigen in the perphery they canot respond to the self
antigen and lose the expression of cell-surace IgM. Ths was shown by adoptively
transfening trsgenic B cells specifc for HEL into an envionment where their auto-
antigen was expressed in the periphery, i.e., by using iradiated ML5 HE trsgenic
mice, with high seru levels ofHEL, as recipients (68). The same results were found 
matig the HEL-spifc B cell-trsgenic mice to ML-4 metalothionein-HEL-trsgenic
mice, that express 10- fold lower levels of HEL than the ML5 mice. The trsgenic B cells
in these animas were not tolerant, but when the concentration of HEL was increased, by
feedg the mice zic in their drnkg water, the previously non tolerat periphera HEL-
specfic B cells were inactivated, as shown by downegulation of surace IgM and an
inabilty to mount a HEL antiboy response (68).
T cell tolerce to periphera self antigens is most liely mataed by one of the
mechansms: clonal anergy or inactivation, clonal ignorance, and/or suppression. Anergy is
the result of T cells reognizig antigen presented by AP in the absence of costimulation.
T cells inactivated in ths way wil not proliferate in response to antigen even if it is
subseuently presented by an AP expressing costiulatory molecules, beause they 
unable to prouce their autoce grwth factor, IL-2, which prevents them frm
proliferatig and differentiatig into effector cells. This may be one way of mataing T
cell tolerace to tissue antigens. Anergy was fit shown using paronnaldehyde-fixed
AP, which have lost the expression of costimulatory molecules, to present antigen to Th1
cell clones (69). Anergy in vitro has also ben demonstrted using pured class II
molecules on planar membraes (70), and IF- induced class II-expressing keratiocytes
(71).
An in vivo model of T cell anergy was shown by Burkly and colleagues, in which
the class n MHC molecule, I- , was expressed only on pancreatic f3-cells in mice that
noraly lacked I-E (72). In a mixed lymphocyte culture, the T cell proliferative responses
to the I-E antigen were quite reduced in the trsgenic anmas. These T cells were also
unrsponsive to TCR-crosslinkng, and it was shown that the unresponsiveness was not
due to deletion, as the Vf317+ T cells specifc for I-E plus superatigen could be detected 
the pephery. Another in vivo example of anergy has been demonstrted by injectig Mls-
1& -bearng spleen cells i. v. into Mls- 1 b mice. Vf36+ T cells, reactive to MIs- , were not
delete in the Mls- 1 b mice, but persisted as unrsponsive cells that were unable to prouce
IL2 (73). Recent researh has shown that T cell anergy is due to an early block in the Ras
signaling pathway, thus the abilty to produce IL-2 is lost (74, 75).
The send possible mechansm for mataing T cell tolerce to self antigens in
the periphery is ignorace. In ths cirumstace the self antigen may be present at such a
low concentrtion or may not bind well enough to the MHC molecules that it is not
presented effciently in the thymus, and therefore the autoreactive T cells are not delete.
Although the autoreactve T cells are present in the periphery, they do not nonnally respond
to the self antigen, most liely because it is presented poorly, and are said to be in a state of
imunological ignorance. T cell ignorace was shown by Ohashi and colleagues in
double-trsgenic mice that expressed the LCMV lymphocytc choriomenigitis 
glycoprotein on the pancreatic 
-cells in TCR trsgenic mice in which the TCR was
speifc for LCMV and H- (76). The autoreactive T cells were not delete and did not
attk the pancrtic 
-cells, but CD8+ T cell-meated diabetes resulte when the double-
transgenic mice were infected with LCMV. This result suggests that the auto-antigen was
not previously presented in a maner to alow for T cell activation, and activated T cells
could enter and destry islets.
The th mechansm for periphera T cell tolerance is suppression. In suppression,
one population of antigen-speifc T cells actively suppresses the imune response of
another population of T cells. Ths was shown by Kumar and Sercar when they found
that the injection of T cell clones, specific for a TCR peptide presented by class II MHC,
could protect naive mice from MBP-induced EA (77. Another grup was able to protect
rats against MBP-induced EA by injectig a synthetic peptide representing the
hyprvarable region of the TCR V 8 molecule prior to challenge with MBP in adjuvant
(78). Cytotoxic CD8+ T cells may provide an adtional way to suppress an imune
response. For example, T cell suppression of humora responses resulte frm the abilty
of class ll-restrcted CD8+ cytolytc T cells (CT) and CD+ CT to lyse antigen-specifc B
cells presenting exogenous protein antigens (79). Although suppression can be
demonstrted in severa experental systems, the exact mechanisms of antigen reognition
and suppression ar not fInnly established. It is also unkown whether suppressor cells
playa role in the maitenance of self tolerace. However, reently Powre and colleagues
published evidence that CD45RB Th cells were capable of suppressing CD45RBhi Th1
cells that medated both a protective response agaist Leislunia major and a pathogenic
response against a self antigen (80).
E. Acquired Tolerance
One way to understad the mechanisms of peripher tolerace to self proteins is to
stuy acui tolerace to foreign prteins. In acquired tolerace previous exposur to
antigen under cert conditions results in antigen-speifc nonresponsiveness instead 
prig for a seconda response. Like perphera self tolerace, acquired tolerace
involves inctivation of matu T cells. The fIrst experients on acquied tolerace were
perfonned in the 1960's, when it was shown that the factors give rise to acquired
tolerance: the route of antigen adnistration, the dose, and the fonn of the antigen. When
soluble protein antigen is adnistered either Lv. or Lp., by repeated injections of low
doses (10 Jlg) or one high dose (1 mg), in a deaggrgated fonn, a subsequent
imunogenic challenge of antigen in CFA reveas antigen-specifc unrsponsiveness.
Severa different antigens, bovine serum albumi , human gama globulin, bovine gam
globulin, and flagellin , were found to induce acquied tolerace when given in this maner
(81-86). The antigen-presenting cell responsible for acquired tolerace to soluble proteins
has not been identified, but experments perfonned in our lab indicated that B cells can be
tolerogenic AP.
The fit evidence in our lab that sma restig B cells could be tolergenic AP for
T cells was demonstrted by Elibeth Eyon in experients where antigen was tageted to
smal resting B cells (87). She injected naive mice with deaggregated rabbit anti-mouse
IgD Fab frgments and then chalenged them with alum-precipitated Fab non-immune
rabbit imunoglobuli. Antigen presentation was lited to restig B cells, because they
express the IgD B cell reeptor, and they can proess and present Fab fragments while
remaning in a resting state. Animals trated in ths manner were profoundly tolerat, 
shown by a signifcant reuction in antiboy production. Victoria Yuschenkoffprovided
adtional evidence that restig but not activate B cells could be tolerogenic AP (88).
When she injected spleen cells frm trsgenic mice expressing the hum Jl chai on the
surace of mouse B cells into their nontrsgenic littenntes tolerace was induced as
meaur by antiboy prouction, to the huma Jl chai. Injection of spleen cells frm
double-trsgenic mice, expressing both the hum Jl chai and the costiulatory molecule
B7-1 on B cells, did not induce tolerance, indicatig that only resting B cells could be
tolerogenic. These findings along with those of others show that smal resting B cells,
which can proess and present antigens but which lack costiulatory activity, can act as
potent tolerg AP for matue peripher T cells (87-93).
Prsentation of soluble antigen by antigen-specifc B cells is parcularly effcient at
low antigen concentrtions, beause B cells can use their antigen receptors to captu and
concentrte soluble antigen and deliver it into an antigen-processing pathway. Thus, at low
antigen concentrtions, the only cells capable of bindig enough antigen to allow specifc
reognition by T cells may be the antigen-specific B cell. Therefore, I considered the
possibilty that ra antigen-specifc B cells playa necessar role in self tolerace to low
concentrtions of soluble self proteins and in acqui tolerace to low doses of soluble
foreign protein antigens.
This thesis exames the role of B cells in tolerace to low doses of self and foreign
protein antigen by comparng tolerce induction in nonnal and B cell-deficient anims. In
the fit set of experiments, T cell proliferation assays were performed to detennne
whether B cells were necessar for in vivo prig of naive T cells. In the next
exprients, I examned the effect of treatment with low doses of antigen on the resultig
imune response following chalenge with antigen in CFA by measurg antiboy titers in
untrated and trated noral anims. I also examed how low doses of antigen afected
the development of CD+ T helper cell subsets by measurg cytokine production frm T
cells stimulated in vitro. Finally, in experiments perfonned in two diferent haplotyes of
transgenic anmas, I addressed how the efficiency of antigen 
prsentation can affect
tolerace induction.
CHTER II
MATERIALS AND METHODS
. C57BU6, B 1O.A, and C3H mice were purhased frm the National Cancer
Institute (Freerick, MD). The mice were 6-20 weeks old at the sta of each experient.
B cell-deficient Jl mice (16) were obtained from Dr. Charles Sidm (University of
Cincinnati, OH) and wer bre at the University of Massachusetts Medcal Center
(UC) anim facility. The mice were backcrossed six generations to the Jl C57BU6
str. The B cell-deficient mice were mataed on SulfaTri Pedatrc Suspension
(Bar-National Inc., Baltimore, M. ) containg 1280 mg sulfamethoxazle and 256 mg
trethopri per liter of drnkng water, for one week ever other week. C57BU6 mice
trsgenic for hen egg lysozye (H) lined to the zic-inducible mouse metaothonein
promoter were kidly provided by Dr. Chrs Gooow (Staford University, Palo Alto,
CA) (94). HE trsgenic mice of the ML-4line have a basal seru concentrtion of 
of c: 0.5 ng/ml, and the ML- HE trsgenic mice have 20 ng/ml of serum HE (94). B
cell-deficient mice carg the HE trsgene on the H- b1b backgrund were generated by
matig mae mice of the ML-4 lie to B cell-deficient femae mice and backcrssing the
HE trsgenic progeny to B cell-deficient mice. To intruce the high responder H-
haploty, these HEtrsgenic, B cell-deficient mice were br to H- " mice that were
heterozygous for the Jl disrpted Jl heavy chain locus. The latter were (B 1O.BR x
JlT) F2 mice given to us by Dr. Anthony Vella (National Jewish Center, Denver, CO).
We scned for B cell-deficient mice by testig peripheral bloo obtaed frm the
progeny at 6 weeks of age for the absence of B220+ cells by flow cytometr as descbe
below. Femae CBA (H-T) and B 10.A (H- ) mice were bre to male mice of the HE-
,c-
trsgenic ML-4line to crate F1 (H- bJk or H- b/a HE trsgenic and nontrsgenic
mice. Al anims wer mataned in micrisolator cages under spefic pathogen-
conditions.
Anti ens. HE, OV A, and pigeon cytochrme c (PCC) were purchase from
Sigm Chemical Co. (St Louis, MO). HE was furer pured by gel fItrtion over a
G75 Sephadex colum in 5% acetic acid and by HPLC in 0. 1 % trfluoroaetic acid with a
60% linear grent of acetonitre in the Peptide Synthesis / Antiboy Production core
facilty at UMMC. PCC peptide 81- 104 and the HE peptides (20-35, 30-43, 46-61, 74-
88, 81-96, 116-129) were synthesized in the UMMC Peptide Synthesis / Antiboy
Pruction core facilty. The pured protein dervative of Mycobacteriwn turculosis
(PPD) was prepar frm desiccated M. tuberculosis H37RA microorgansms (Dfco
Laboratories, Detrit, Michigan) according to a protool frm Paul Alen (pernal
communication). Briefly, M. tuerculosis organsms were suspended in PBS at 100
mg/ml, homogenized by bref sonication, and then clarfied by centrgation at 14 00 rpm
using a Beckman JA- 18. 1 fixed angle rotor (Beckman Instrments, Inc., Palo Alto, CA)
for 20 minutes at 4 C. The supernatat was removed, filtered successively thugh 0.45Jl
and O.22Jl rnlipore fiters, and store in a frezer at - C. PPD was used at a fmal
diution of 1:200 in all assays.
Other Rea ents. Al LN, spleen, and purfied T cell proliferation assays were
peored in Dick' s medum (Ire Scientic, Santa Ana, CA) with 10% feta bovine
sem (FS) (Hyclone Laboratories, Logan, UT. Cells were harested and washed in
either RPMI 1640 tissue cultue medum (Gibco BRL, Gaithersburg, M. ), or Ix
Balced Salt Solution (BSS), made in the deparenta meda facilty, with 1.5% FBS
aded IL2 and IL4 sensitive cell lies were mataed in RPMI 1640 (Sigm Chemical
Co.) with 10% FBS added. Additional reagents ar listed below as needed
Identification of HEL Tras enic Mice. The HEL transgene was detecte by PeR.
DNA was obtaed from tisue derived from ear punch markig as previously descbe
(95). Briefly, ear tissue was added to 20 JlI of 50 mM Tris-HCI (pH 8.0), 2 mM NaCI, 10
mM EDTA, 1 % SDS, and 1 Jl of 20 mg/ml proteinase K. The mixtur was incubated
twce at 55 C for 15 min., with vigorous vonexing after each incubation. Distiled water
was aded to a fial volume of 200 Jl, and the mixtu was heated for 5 min at l00C and
used in the PCR reaction afer cooling or stored at 
- 20 C. PCR reactions were perfonned
in a fmal volume of 50 Jl, consistig of 1 Jl of DNA and 49 JlI of a reaction mix
contaning 5 JlI of a lOx amplifcation buffer (670 mM Tris-HCI pH 8.8, 160 mM
(N4 4' 25 mM MgC4), 5 Jl of 50 mM 2-mercaptoethanol (M), 20 JlI of a
deoxynucleotide trphosphate mix (312 Jl each of dATP, dTT, dGTP, dCT)
(Boehrnger, Mannheim, Indianapolis, IN), 1 JlI (1.5 units) ofTaq polymerase
(Boehrnger, Manheim), and 18 Jl of the oligonucleotide primers (50 ng ofHE3F, 33.
ng ofHEL4R, and 30 ng of each of the endogenous Ig primers). The 50 Jl reaction mix
was then layere with 60 Jl miera oil (Sigma Chemical Co.). The PCR reaction was
perfor using two sets of primers, one set for the HEL trsgene and another set for an
endogenous Ig gene. The HE prier sequences were HEL3F: 5'
- GAG CGT GAA CIG
CGC GAA GA- , andHER: 5' - TCG GTA CCCTTG CAG CGG TT-3' (Bio-
Synthesis, Inc., Lewisvile, TX) (C. Gooow, personal communication). The
endogenous imunoglobulin gene primer sequences were sense: 5' CIG GAG CCC TAG
CCA AGG AT , and antisense: 5' ACC ACA GAC CAG CAG GCA GA-
. The 
priers amplified a 160 bp trsgenic bad in trsgenic animals only, and the Ig primers
amplifed a 264 bp endogenous band in al animals. PCR was perfonned using a Hybaid
therm reactor (National Labnet, Co., Woobrdge, NJ) under the followig conditions:
intial denatution at C for 5 min. , followed by 30 cycles of 1 min. at 94 C, 1 min. at
C, an 1.5 min. at 72 C, followed by a 9 min. elongation at 72 C. To visuale the
PCR-amplied DNA, 5 JlI of loadng buffer (Promega, Madison
, WI was added to a 20 Jl
alquot of the reaction, loaded onto a 2% agarse gel along with a 123 bp DNA ladder
(Gibco BRL), and electrphoresed The gel was then staned with ethidium bromide, and
the DNA bands wer visualze by ultrviolet transilumation.
Flow Cytomett. B cell-deficient HE transgenic (H-2b1) and (H- b1a) Fl mice
were identied by testing for the absence of B cells by fluorescence staning of B220 on
periphera bloo lymphocytes. Bloo, 300-500 JlI, was collected from the tal veins of
mice into tubes containg 50 JlI hepar (1000 U/ml) (Elkn-Sinn Inc., Cherr Hil, NJ) in
5 ml RPMI 1640 plus 1.5% FBS, and then centrfuged for 10 miutes at 1400 rpm in a
Sorvall RT60 centrfuge (Dupont, Wilmington , DE) at 4 C. Red cells were lysed with
500 JlI Tris pH 7 . CI at 37 C for 5 mi. Remaining leukocytes were washed once
with medum, and centruged for 8 miutes. Cells were then resuspended in 50 JlI F ACS
buffer (PBS with 1.5% FBS and 0. 1 % sodum azide), transfelTed to V-bottom tubes, and
kept on ice durg the staing protocol. The cells were fist incubated for 30 minutes with
a 1:100 diution of anti-B220 antiboy, RA3.6B2 (D. Nancy Phillps, UMC), then
washed once in FACS buffer, centrfuged, and resuspended in 50 JlI FACS buffer. Next,
a 1:60 dilution of mouse anti-rat kappa FIC-OX12 (Serotec, Ltd., Oxford, UK) was
adde, the cells were incubated for 30 minutes, and then washed twce with FACS buffer.
After the seond wash, the cells were resuspended in 100 Jl FACS buffer and fixed for 5
minutes at rom temperatu by addig 40 Jl of 4% parormdehyde. The fixed samples
wer washed twce with FACS buffer and resuspended in a final volume of 250 Jl FACS
buffer. The saples were analyze by the UMMC Flow Cytometr Facilty.
Tolerace inducton. HE or OVA were centrfuged at 160,00 g in an aiuge
(Beckm Instrments, Inc.) for 60 miutes imedately before injection, and the top thd
of the solution was used. Ultrcentrfuged HEL or OVA were dilute to a concentrtion of
50 Jlg/ml in PBS, and 0.2 ml was injected intravenously into the latera ta vein of
C57BU6 and of homozygous JlT B cell-deficient mice thee ties a week for the
weeks. Seven days after the last injection the mice were challenged subcutaeously in each
hind footpad with 20 Jl of 100 Jlg HE or OVA in complete Freunds adjuvant (CFA)
(Difco Laboratores).
Prliferation assays. Prliferation assays were set up with either whole LN cells,
pured T cells (see below), or spleen cells. Mice were chalenged with 20 JlI of 100 Jlg
HE, OVA, or PCC emulsifed in CFA in each hind footpad. Ten days later the animas
were saced the popliteal lymph nodes were harested and single cell suspensions
were mae. Spleens were harested from mice 28 days after challenge, and the red bloo
cells were lysed with Tris pH 7.2 NH Cl. Both LN and spleen cells were washed and then
counte. Whole LN cultus or spleen cells frm individual animals were set up at 2 x 10
or 4 x 105 cells/well in trplicate in 0.2 ml in flat-bottom 96-well plates in Click' s medum
(Ie Scientic) with 10% FBS (Hyc1one Laboratories) with 100 U/ml penicillin, 100
Jlg/ml streptomycin, 2 mM I-glutae, and 5xlOos 2-ME added. The plates were
incubate at C for 96 hour in 5% and pulsed with 1 JlCi eRJ thymidie (TdR)
(Amersham Corporation, Arlington Heights, IL), speific activity 5 Ci/mmol, for the last 6
hour. Assays were haested on a Walac cell harester (Gaithersburg, MD) and counte
using a Beta-Plate counter (Walac).
Pro iferatio assa,ys with pured cells. Mice were chalenged and LN cells were
harested as above. The LN cells were incubate at 4 C for 30 miutes with a rat anti-class
II antiboy, M5/114. 15. , that recognizes I-Ab,d,q and I-Ed.kwith or without anti-B220,
RA3.6B2 (D. Nancy Phillps). T cells were then pured by paning on rabbit anti-mouse
Ig-coated plates at 4 C by the method of Wysocki and Sato (%). Spleens of naive
C57BIj6 mice were used as a soure of APC and were depleted of T cells as previously
describe (97). Briefly, the red bloo cells were lysed with Tris pH 7.2, CI and
washed. An anti- T cell cocktal, consisting of anti- Thy- , anti-CD, and anti-CDS
antiboes, was aded and the cells were incubated on ice for 30 minutes. After a single
wash, a mouse anti-rat 1C antiboy was added, and the cells were incubated on ice for an
adtional 30 miutes. Agarse-absorbe guinea pig complement was added ditly, the
cells were incubated for 30 miutes at C, and then they were centrfuged for 10 minutes
at 1400 rpm. Next, the cells were overlayed onto high density Ficoll hypaque (p = 1.09),
centiged for 20 minutes at 300 rpm, and the interface cells were collected and washed.
Six x 10 purfied T cells were incubated with 2 x 10 irdiated (300 cGy) AP. The
cultus were pulsed and harested as above.
B cell urica on. Spleens were harested frm naive C57BIj6 mice and single
cell suspensions were made. The red bloo cells were lysed with Tris pH 7.2 NH CI,
washed and then depleted of T cells as above. Following the T cell depletion the cells
were washed twice, counted, washed again in RPMI 1640 without seru, and
resuspended in RPMI 1640 without seru at 1 x 10 cells/ml (0. 1 ml cells/thigh) or 2 x 10
cells/ml (0.2 ml cells Lv.) for trsfusion into B cell-deficient mice.
A. Anti-OVA antiboy titers were detered using the previously descrbe
sadwich ELISA (87). Briefly, the plates were coate with OVA, blocked overght with
PBS+ 1 % BSA, and washed with PBS/0.05% Tween. Serial thee-fold dilutions of mouse
sera stag at 1:40, in PBS+ 1 % BSA , were perfonned, and the plates were incubate at
rom temperature for 30 minutes. The plates were washed, then incubated with
peroxidase-conjugated goat anti-mouse IgG + IgM (H + L chais) (Jackson
Immunoresearch Laboratories, Inc., West Grove, PA), developed with 3, 3'
, 5, 5'-tetr-
methyl-benzidine (ICN Biologicals, Lisle, IL) with H
, and stoppe with 2 M H S04.
The plates were read at 450 om on a plate reader (Molecular Devices Corp., Sunnyvale,
CA). The stadard for these assays was an anti-OVA hyperimmune serum. The isotye of
the anti-OVA antiboes was determned by using a mouse monoclonal antiboy isotying
kit (Zymed, San Fracisco, CA). The kit included the biotiylated anti-mouse antiboes
IgGl , IgG2a, IgG2b, and IgG3, HR-Streptavidin, and 2 azno-di(3-
ethylbenzthiazoline sulfonic acid) (ABTS) substrte. Mouse ser was initialy dilute
1:40 for IgG 1 measurment, 1:5 for IgG2a measurement, 1 :200 for IgG2b measurement,
and 1: 10 for IgG3 measurment, and furer serial two-fold diutions were perfonned. The
plates were washed with PBS/0.05% Tween, the appropriate biotinylated antiboes were
added, and then the plates were incubated at 37 C for 30 miutes and washed again. Next,
HR-Strptavidi was diluted 1 :50, added to the plates, and another 30 minute incubation
at 37 C was perfored. The plates were developed at rom temperature with ABTS,
diuted 1:50 in substrte buffer contaning 0. 1 M citrate pH 4.2 with 0.03% H , and read
at 405 nm. Stadar plates were coated with phenylaronate-BSA, followed by pured
monoclona mouse anti-phenylaronate IgGl , IgG2a, IgG2b, and IgG3 antiboes,
provided by Dr. Nancy E. Phillips (98). The isotye concentrtions of the mouse seru
saples were detenned by comparng O.D. values, corresponding to the linear porton of
the stadad cure, with those of the stadads.
IF-y detec on b ELISA. 150Jl of cultue supernatat was collecte at 72 hours
frm OVA-prime LN cells set up at 6 to 8 x 10 cells/well in Click' s medum in 96-well
plates. At the sta of the in vitro incubation, 100 Jlg/ml OVA or PPD were added to the
cultues. For the ELISA, Falcon microtiter plates (Becton Dickison
, Oxnard, CA) were
coate overnght with 50 Jl of purfied mouse anti-IF-y (pharngen, San Diego, CA) at
2 Jlg/ml and then blocked overght with PBS/IO% FBS. The plates were washed with
PBS/0.05% Tween-20, 0.2 ml of supernatat was added, serial two-fold dilutions were
perfonned, and then the plates were kept at 4 C overight. After washing the plates, 100
Jl of biotiylated mouse anti-IF- (Phargen) at 1 Jlg/ml was added, and the plates
were incubated at room temperatue for 45 miutes. The plates were washed agai, and
incubate at rom temperatu for 30 miutes with 100 Jl of a 1:40 dilution of 1 Jlg/ml
avidi-peroxidase (Sigm Chemical Co.). The plates were develope with the substrate
ABTS (Sigma Chemical Co.) with H aded. The concentrtion of IF-y was
deterned by comparg the O.D. values of the samples with the pured reombinant
mouse IF-y stadard (pharngen).
IL-2 and IL-4 ection b bioassa . Supernatants were collected at 24 or 48 hour
frm OVA-primed LN cells set up at 6 to 8 x 10 cells/well in Click' s medum alone or with
PPD or 100 Jlg/ml OVA. The concentration of IL-2 was detened by the proliferation of
the IL-2-dependent cell line, HT-2. HT-2 cells were set up at 2 x 10 cellslO.2 mVwell in
96-well flt bottom plates in duplicate with two-fold serialy 
diuted cultue supernatats.
The cultues were pulse with 1 JlCi eHJTdR for the last 4 hour of the 24 hour
incubation. Recombinant mouse IL-2 (D. Nancy E. Phillips) (99) was use as stada
in the assay. In some experiments, IL-2 activity was blocked using the monoclonal anti-
IL-2 antiboy (S4B6, from Dr. Tim Mosmann
, University of Albert, Edonton
Caad), and IL-4 activity was blocked using anti- IL-
4 (11 B 11 , from Dr. Wiliam Paul
National Institutes of Health
, Bethesda, MD). The concentrtion of IL-4 activity was
detennned by the prolieration of the IL- dependent cell line, CT -4S (provided by Dr.
Wiliam Paul), as previously descrbe (100). Briefly, serial two-fold dilutions were
perfonned on the cultur supernatats, and the assay was incubated for 24 hour and then
pulsed overnight with 1 JlCi eH)TdR. The IL-4 standard used in the assay was provided
by Immunex Corp. (Seatte, W A). Assays were harested and counte as above.
tatistical Anal sis. Signifcant diferences between grups were evaluated using a
two-taled Students t-test assumg equal varances. Statistical analysis was perfonned
using a genera mixed model analysis of varance (BMDP Statistical Software, Inc., Los
Angeles, CA).
CHTER III
T CELL PROLIFRATNE RESPONSES IN NORMAL
AND B CELL-DEFICIENT ANIALS
The goal of my experments was to determe whether B cells were requi for
tolerace induction to low levels of soluble protein antigen. The most diect way of
adssing the reuirment of B cells in tolerace induction was to induce tolerace in the
absence of B cells, using Jl B cell-deficient mice (16). I decided to measur tolerace
induction in the B cell-deficient mice by T cell proliferation assays. As discussed below,
the role of B cells in priming naive T cells to whole protein has been contrversial in the
literatu, and my fit ai was to determe whether I could measure T cell proliferative
responses in the absence of B cells.
A. T Cell Proliferative Responses are Reduced in Cell-Deficient Animals
Before I could examne the proliferative responses of the B cell-deficient animals, I
needed to establish a protocl that measur T cell proliferative responses in norm mice.
I examed many parters for the assay: the site of injection, the drning lymph nodes
with the highest number of respondig cells, the day ofLN harest post-chalenge, the 
vitro cell densities necessar for an optima response, and the antigen specifcity of the
response. Thus initial experments indicated that the most effective site of injection was the
hid footpad, instead of at the base of the ta. The antigen-specifc T cells were confned
to the drning popliteal LN, because no proliferation was observed when assays were
perfonn with cells frm the inguinal LN. I also found that 10 days post-chalenge was
the opti time for harestig the LN T cells. Therefore, in all of the proliferation assays
shown, unless otherwise noted, mice were injected with antigen in adjuvant in the hind
footpads and the popliteal lymph nodes were harested 10 days after chalenge and set up
in vitro with varous antigens.
As shown in Fig. 1, I addessed the question of antigen specificity by pring
noral mice with CFA alone or with OVA emulsified in CFA. Ten days later, LN cells
were set up in vitro in medum alone, or with PPD, a component of the adjuvant, or with
incrasing doses of antigen. Lymph node cells both from nonnal mice pried with CFA or
OVA in CFA proliferated to the antigen found in the adjuvant, PPD. Only LN cells from
mice prmed with OVA in CFA proliferated to OVA, and this proliferative response was
dependent upon the dose of OV A in vitro. The proliferative response of both grups of
anmals was better at 4 x lOS cells/well than 2 x 1 OS cells/well. The response of the LN cells
frm mice pried with CFA alone indicated that the OVA-specifc prolierative response
was due to the presence of OV A in the adjuvant, and therefore I did not continue to include
the CFA control in my experiments.
After establishing the conditions of the T cell proliferation assay in nonnal mice, I
was ready to test the proliferative responses of the B cell-deficient anmas. First, I wanted
to ensur that the B cell-deficient mice, crated by tageted gene disruption of the
transmembrane porton of the IgM molecule, did not contan any matu B cells (16).
Periphera bloo frm norm and B cell-deficient mice was staed for the B cell antigen
B220. The results shown in Fig. 2 indicate that the perpheral bloo of the B cell-deficient
anmas was completely negative for B220+ B cells. These results confied the findings
that B cell precursors faied to progrss beyond the early pre- B stage, as shown in the
initial descption of the Jl B cell-deficient mice (16, 101).
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Figure 1. Two mice were pried with CFA and the mice were primed withOVA emulsifed in CFA. Ten days later, the popliteal lymph nodes were harested
and the cells wer cultu in trplicate in vitr at the cell densities indicate in
medum alone (B), PPD (P), or incrasing doses of OVA. Cultues were pulsed
with (3H)TdR the last 6 hours of a 96 hour incubation. Errr bar represent 1 SD.
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Figure 2. Expression of B220 on peripheral bloo lymphocytes frm C57BL/6
or B cell-deficient mice. Lymphocytes were staned with a rat anti-mouse B220
monoclonal antiboy, followed by mouse anti-rat kappa FIC-OX12. The panels
on the left represent lymphocytes staned with the second antiboy only. The mean
channel fluorescence in the C57BL/6 mice is 90.
After config the absence of B cells in the B cell-deficient animals, I was ready
to test the T cell prliferative responses in these mice. Earlier experients peronned in
ans mae B cell-deficient by anti-Jl tratent indicated that B cells were necessar for
effcient priming of naive T cells (102-105). Other experients peronned in SCID mice
renstitute with T cells alone and perfonned reently in Jl mice demonstrted that T
cells can be effectively prime in the absence ofB cells (101, 106, 107). To test T cell
proliferative responses in the absence of B cells, I primed nonnal mice and B cell-deficient
mice with OVA in CFA and set up LN T cells with antigen 10 days post-challenge. The
results of the proliferation assay shown in Fig. 3 demonstrte that the LN cells from norm
animals were responsive to PPD and OVA. However, the overall proliferative response of
LN T cells from B cell-deficient anmas to both these antigens was 5 to 10-fold lower than
the prlierative response of cells frm norm anmas. Since the ultiate goal of 
experients was to measur tolerce induction by T cell proliferation in individual B cell-
deficient mice, the next set of experents were designed to improve the antigen-specifc
response of LN cells from B cell-deficient anims.
B. B Cells Contribute to in vivo Priming and in vitro Proliferation of T Cells
The dierences in the proliferative responses between the nonnal and B cell-
deficient anmas suggested that antigen presentation by B cells in vivo and/or in vitro may
enhance the T cell proliferative response of the nonnal anmas. Firt, I decided to
investigate the role of B cells in primig T cells in vivo. The importce of B cell antigen
presentation to T cells in vivo was initialy report by Ron and Sprent in experiments with
mice treate with anti-Jl. They found that the proliferative response of these B cell-deficient
LN Proliferative Responses are Reduced in
B Cell-Deficient Animals
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Figure 3. Six noral and six B cell-deficient mice were pried with OVA
emulsifed in CFA. The popliteal lymph nods were hareste 10 days later.
Cells wer pooled from each grup and set up in vitr at 4 x IOS cells/well in
trplicate in medum alone (B), PPD (P), or incrasing doses of OV A. The
cultues were pulse with rH)TdR for 6 hours at the end of a 96 hour
incubation. Err bar represent 1 SD.
anims was restored by subcutaneous (s. ) injection of B cells prior to s.c. injection of
antigen in CFA (103). To test whether I could reprouce their fmdings, I injected B cells
Lv. or s.c. into the JlMT B cell-deficient anmals prior to pring with OVA in CFA. As
shown in Fig. 4, although the proliferative response of LN cells frm nonnal animas
remaed much higher than the response of LN cells frm the B cell-deficient anmas with
or without the addition of B cells in vivo, it appear that the in vitro proliferative response
of at least 3 out of 6 B cell-deficient anmas was improved by the injection ofB cells i.
prior to chalenge. The s.c. injection of B cells also seemed to enhance the OV A response
ofLN cells from 4 out of 5 B cell-deficient mice. Unfortnately, these findings were not
consistently reproducible; therefore, I decided to examne the contrbution of B cell antigen
presentation in vitro to the T cell proliferative response (l08).
One way to test whether B cells were importt for T cell proliferative responses 
vitro was to provide additional APs in the in vitro cultus. I decided to test two different
AP populations: naive APC from T -deplete spleen cells, and OVA-primed AP frm 
deplete LN cells of norm mice pried with OVA in CF A in the hind footpads. Norm
and B cell-deficient mice were pried with OVA in CFA, and the two diferent 
populations were added in vitro to the LN T cells. The results shown in Fig. 5 indicate that
the adtion of either naive APCs or OVA-primed APCs to LN cells frm B cell-deficient
anmas did not enhance the prolierative response to antigen in vitro. The prolierative
response of the nonnal animals was slightly enhance by the addtion of OVA-pried
APC.
. .
Addition of B Cells in vivo to B Cell-Deficient
Mice Improves Their Proliferative Response
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Figure 4. Six B cell-deficient mice were trsfused with 40 x 10 B cells i. v.
and 5 B cell-dficient mice were trsfused with 1 x 10 B cells s.q. C57BU6,
untrated B cell-deficient mice, and the trsfused B cell-deficient mice were
pried with OVA in CFA and LN cells were harested 10 days later. Whole
LN cells frm C57BU6 mice were set up in trplicate in vitr at 4 x 105cells/
well and LN cells frm B cell-deficient mice were set up at 2 x 105 cells/well
in medum alone (B), PPD (P), or OV A. Symbols represent individua animals
and the group average is represente by the bar. The cultus were pulsed with
H)TdR the last 6 hour of a 96 hour incubation.
APC Addition in vitro does not Alter the Reduced
Proliferative Response of B Cell-Deficient Mice
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Figure S. Thee C57BU6 and 4 B cell-dficient mice were pried with 400 Jlg
OV Nfootpad. Ten days later LN cells were hareste from each grup. LN
cells were set up in trplicate as shown at 2 x UP cells/well in medum alone (B),
PPD (P), or OV A. Spleen cells from an unpried C57BL/6 mouse were T -depletedirate and use as APC. OVA-pried LN cells from 2 of the C57BL/6 mice
were depleted of T cells, irdiated, and used as OVA-primed APC. Culturs were
- incubate for 96 hours and pulsed with (3H)TdR for the last 6 hours. Cells were
poled frm 3 mice in the top grph, symbols represent individual animals in the
bottom grph, and the bars represent the mean. Error bar indicate 1 SD.
C. Proliferation Assays Performed with Purified T Cells
mo dit way to test for the contrbution of B cell antigen prsentation in vitro
was to pur the T cells frm the norm and B cell-deficient mice and ad nonnal splenic
AP to the prolieration assay. Norm and B cell-deficient mice were pried with OVA in
CFA, and T cells were purfied frm lymph nodes harested 10 days post-chalenge. The
pured T cells were set up in vitro at two different cell densities with or without addtional
APs aded to determe the effectiveness of the purcation. As shown by the left panel
of each grph in Fig. 6, there was a slight response to PPD and OVA in the absence of
adtional APs, indicatig that there wer a few contaating APCs remaing after the
purfication protocol. The T cell proliferative responses of both the norm and B cell-
deficient mice incrased in the presence of additional APCs, as shown on the right panel of
each graph. Also, the prolifertive response of T cells from B cell-deficient anmas to
OVA was now significantly above background (pc:0.OO2 for 6 x leY T cells, and pc:.
for 4 x 1cf T cells). The proliferative responses of both groups of mice were not
signficantly afected by the two diferent T cell densities tested. These results indicate that
the purcation of pried LN T cells reuced but did not abolish the difference between the
proliferative responses of nonnal and B cell-deficient anmas.
D. Peptide Priming in the Absence of B Cells Improves
Cell Proliferative Responses
It had been suggested that diferent fonn of antigen, i.e. whole protein or peptide,
reui distict APCs for T cell prig (109). B cells were reuir for presentig
Proliferation Assay Performed with Purified T cells
from Normal and B Cell-Deficient Mice
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Figure 6. Seven C57BU6 and 7 B cell-deficient mice were primed with OV A in
CFA. Lymph nodes were hareste 10 days later. T cells were pured and set up
in trplicate in vitr at 4 x 105 (dotted bar) or 6 x 105 (gray bars), with or without
irated APes aded, in medum alone (Bgd), PPD, or OVA. The cultus were
pulsed for 6 hours with (3H)TdR at the end of a 96 hour incubation. Eror bars
represent 1 SD.
whole protein, whereas peptide antigen was presented most efficiently by dendrtic cells.
Therefor, an additional possibilty for the proliferative dierences observed between
norm and B cell-deficient anmas could have been due to the fonn of antigen used for T
cell prg in vivo. I peormed the experents using either pigeon cytohrme c
(PCC) whole protein in CFA or PCC peptide in CFA to prme nonnal and B cell-deficient
mice. The results of the only experiment testig the proliferative response of pured T
cells ar shown in Fig. 7. In general, LN cells from mice primed with whole protein
proliferated better in vitro to the whole protein antigen than to peptide antigen
, and vice
versa. In this experent, the proliferative responses of the nonnal and B cell-deficient
mice were comparble when the animals were primed with protein antigen. Ths result was
not consistent with my fidings from proliferation assays perfonned with OVA in nonnal
and B cell-deficient animals. The differences obsered in the proliferative responses
between the nor and B cell-deficient mice may therefore depend on which antigen is
use, that is PCC or OVA, as the proliferative response of the nonnal mice to the antigen
PCC was markedy less than their proliferative response to OVA. Prmig with PCC
peptide resulted in a higher proliertive response in the B cell-deficient anims than in the
nors animas
, as the in vitro proliferative response to peptide and whole protein was
grater in the T cells frm peptide-pried B cell-deficient mice than in T cells frm protein-
pried B cell-deficient mice. In two out of the experients I performed, the proliferative
responses of B cell-deficient mice pried with peptide antigen wer better than the
proliferative responses observed frm B cell-deficient mice primed with protein antigen.
The role of B cells in T cell pring to protein and peptide antigen remains
unrsolved, based on the results of my own experiments and also those of others
perfonned in B cell-deficient mice (101 , 110). There ar liely to be many factors that
contrbute to the effciency of T cell prig, and the reuirment of B cells as APC
The Effect of Priming with Whole Protein or Peptide
Antigen on the T Cell Proliferative Response
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Figure 7. Four nonnal and 6 B cell-deficient mice were injected with 8.2 nmoles whole
PCC or 31.25 nmoles PCC peptide emulsifed in CF A in each hind footpad, and 10 days
late LN cells were hareste. Pued T cells were set up in trplicate from each grup at
4 x 105 cells/well along with 2 x 105 irate APCwell in medum alone (B), PPD (P),
PCC whole protein, or PCC peptide. The cultus were pulsed for 6 hours with eHJTdR
at the end of a 96 hour incubation. EITr bars represent 1 SD.
probably depends not only on which antigens were used for the experiments, such as
, OVA, or PCC, but also on whether the T cells were purfied or left unfctionate.
, ,
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TIE ROLE OF B CELLS IN SELF AND ACQUIRED TOLERANCE
The next set of expents was designed to determne whether B cells were
reui for self tolerace to low concentrtions of soluble self proteins and for acquir
tolerance to low dose soluble foreign protein antigens. We thought B cells might be
necessar for tolerace induction to low concentrtions of antigen beause they ar very
effcient APC with low level antigen, and previous studies in our lab had shown that B
cells, which lack costiulator activity, can function as tolerizig APC for T cells.
I chose to use a transgenic mouse strain expressing low levels of HEL as a soluble
serum protein to exame tolerace inducton to a self protein. It was shown by Adelstein
and colleagues that T cells from H- blk HEL trsgenic mice of the ML-4line ar tolerant
to HE, although the HE-specific B cells ar not tolerzed by the very low concentration
ofHE in that parcular trsgenic line (less than 0.5ng/ml HEL in serum) (94). I was
interested in determing whether HEL-speifc B cells were reui as HEL-speific APC 'II
to induce and mata T cell tolerace to ths trsgenic self antigen, which might be
present at a concentrtion too low to be taen up non-specifcally and presente by other
I I
kids of AP. Therefore, HEL-trsgenic mice were bred with Jl B cell-deficient mice
(16), and T cell tolerance to HEL was measur by T cell proliferation assays.
To follow the HE trsgene thughout the breedng scheme, mice were ty 
PCR. PCR was perfonned with two sets of priers, one set for an endogenous Ig gene to
ensure that the PCR reaction was workig, and another set to screen for the HEL
trsgene. The results ofPCR amplifcation of DNA frm non transgenic and trsgenic
littnntes is shown in Fig. 8. The Ig primers amplifed a 264 base pai band in both
PCR Amplification of DNA from Nontransgenic
and HEL- Transgenic Mice
264 bp
160 bp
Figure 8. PCR Analysis of DNA prepared from (C57BU6 x ML4) mice.
PCR was performed with two sets of primers: the HEL primers amplified
a 160 bp transgenic band in the transgenic animals only, and the Ig primers
amplified a 264 bp endogenous band in all animals. A 123 bp DNA
ladder is shown on the left.
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nontrsgenic and trsgenic anims, and the HEL priers amplied a 160 bp bad in the
trsgenic ans only. The HEL-Tg and nontrgenic ans wer thn teste for the
presence of B cells by staning for B220 as shown in Fig. 2.
A. Cell Tolerance to a Transgenic Soluble Self Antigen (HEL) Does Not
Require Cells as Antigen Presenting Cells
The HEL-trsgenic ans wer crte on the C57BU6 bakgrund, and
tolerace to the trsgene-encoed HEL self antigen had ben shown in H-2b1 trsgenic
ans (94). Therefore, I bre H-2'* F1 B cell-deficient HEL-trsgenic anmas to
detee whether B cells were neess to mata self tolerace to HEL. HEL-
trsgenic H-2'- mice an B cell-deficient HEL-trgenic anmas were prime with HEL
in CF A, and the T cell prolierative responses meur. The results of the LN
prolieration assay in Fig. 9 demonstrte that T cells from the norm HEL-trsgenic mice
ar compromise in their abilty to prolifer to HEL, as compa to theT cell
prolierative response to HEL of the nontrsgenic littrmtes (p.OO 1), config the
results of Adelstein and colleagus (94). The tolerae is antigen-speifc, as indicat by
the respons of the T cells frm both the HEL-trsgenic an nontrsgenic litttes 
PPD, a component of the adjuvant The sa pattrn of results was sen in the B cell-
deficient anmas. T cells frm the HEL-trsgenic B cell-deficient mice were unrsponsive
to HEL, but did respond to PPD, while T cells frm the nontrsgenic B cell-deficient mice
prolierate to the highest dose of HEL ill vitro as well as they did to PPD. The differences
obsrved in the T cell proliferative response to HEL betWeen the Fl HEL-trsgenic B cell-
defcient mice and Fl nontrsgenic B cell-deficient mice were also signifcant (p.OO1).
B Cells are not Required for Peripheral
Tolerance to the Soluble Self Antigen HEL
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Figure 9. Six nonnal (H-2b/ ) mice and 6 B cell-deficient (H-2b/k) mice were
injecte with 40 x 106 T-depleted BlO.BR spleen cells Lv. and then with 100 Jlg HEL
emulsifed in CFA/ind footpad. Ten days later the drg lymph nods were
harested. Four x 105 whole lymph node cells were cultu in trplicate with
incrasing doses of antigen and pulse with (3H)TdR the last 6 hours of a 96 hour
incubation. The left side of each grph is the response of cells from the nontransgenic
mice and on the right is the response of cells from the HEL-trsgenic mice. Each
symbol represents an individual animal, and the bar indicates the grup average.
These results incate tht some other AP is responsible for inducing tolerace to HE in
B cell-deficient ML mice either in the thymus or in the perpher.
B. Reduced T Cell Proliferation caused by Repeated Injections of Low
Concentrations of OV A into Mice does not Require Presentation by Cells
To test whether B cells could act as tolerzig APC in the peripher when foreign
antigen was given exogenously, I wanted to compare tolerace induction to foreign
proteins in nonnal and B cell-deficient mice. Firt, to determne whether low zone
tolerace induction could be measur by a reuction in T cell proliferative responses,
nonal mice were injecte with 10 Jlg of deaggregated HEL Lv. thre ties a week for a
peod of th weeks. Then, the trate and untreated mice were chalenged with HE in
CFA, and the LN T cell response to HEL was examned. As shown in Fig. 10, T cells
from untrate nonnal mice responded to PPD, the control antigen, and in a dose-
dependent maner to HEL. Mice trated with low doses of HE prior to chalenge were
responsive to PPD, but proliferation was miimal at the highest HEL concentrtion. These
results demonstrated that I could measur low zone tolerce induction in norm anals
by in vitro T cell proliferation assays.
Migrtion of the HE-responsive T cells out of the LN following treatment with
low doses of HEL was one explanation for the reduced LN T cell prliferative responses
observed in the treated anmas. To addess ths possibilty, I examned the proliferative
response of splenic T cells frm untreate and trated norm mice 28 days after challenge
with HE in CFA. Splenic T cells from untrated anmas were able to proliferate to PPD
and HE, although this response was slightly less than the response observed 10 days
9..
10 100
Jig/ml HEL
Low Zone Tolerance Can Be Measured by
Reduced LN Proliferative Responses
Untreated 10 Jlg HEL I.
10 100
Jig/ml HEL
Figure 10. Six C57BU6 mice were given 10 Jlg HEL Lv. 3 times a week for 3
weeks. Toleri mice and 6 untrated contrls were chalenged 7 days later with
HEL emulsifed in CFA. Ten days post-chalenge the popliteal LN were hareste.
Cells wer set up in trplicate in vitr at 2 x 105 cells/well in medum alone (B), PPD
(P), or increasing doses of HEL. The cultues were pulsed with eH)TdR for the last
6 hour of a 96 hour incubation. Symbols represent individual animals, and the grup
mean is represented by a bar.
post -chalenge from the LN T cells of the untrated animals (Figs. 10 and 11). Splenic T
cells frm the trte anmas wer compromise in their abilty to proliferate to HE, but
not to PPD (Fig. 11), suggesting that the reuced LN T cell responses to HEL observed in
the trate ans was not a consequence of the HEresponsive T cells migrtig to the
spleen followig treatmnt with low doses of deaggrgated antigen.
Aftr establishing that tratment with low doses of HE resulted in antigen-spefic
nonresponsiveness upon subsequent chalenge in nonnal animals, I was ready to adss
whether antigen presentation by B cells was reui for low zone tolerace. Tolerace
induction to low doses ofHEL was compar in nonnal and B cell-deficient animals. The
T cell prliferative response to HEL frm trated nonnal anmas was consistently reuced
but the results of the proliferation assays in the trated B cell-deficient animals using 
as an antigen were inconclusive (data not shown). Ths may have been due to an inabilty
to generate reproucible T cell proliferative responses to the HEL antigen in untrated B
cell-deficient mice. It was also reently shown that the HE antigen could induce B cell
activation, by crssling the B cell antigen reeptor (111). This is probably due to the
abilty of HE to bind to seru proteins or cell suraces. Because activated B cells have
ben shown to express costiulatory molecules and I wanted to test whether antigen
presentation by restig B cells, in the absence of co stimulation, would result in T cell
unrsponsiveness, I decided to switch to the antigen OVA to compare low zone tolerace
inducton in norm and B cell-deficient mice. In these experients, mice were injected
with 10 Jlg of deaggrgated OVA Lv. the times a week for a period of th weeks. The
trated and untrated mice wer then challenged with OVA in CPA, and the T cell
proliferative response to OV A was examned
Figue 12 shows the results of th low zone tolerance experiments with nonnal
and B cell-deficient mice. In the top panels of Fig. 12, T cells frm norm mice injected
Low Zone Tolerance can be Measured as Reduced
Proliferative Responses in the Spleen
Untreated 10 Jlg HEL i.
100 100
g/ml HEL g/ml HEL
Figure 11. Six C57BU6 mice were given 10 Jlg HEL i.v. 3 times a week
for 3 weeks. The tolered mice and 6 untrate contrls were chalenged 7
days later with HEL in CFA. Twenty-eight days post-challenge, spleens were
hareste frm contrl and tolerze mice and the cells wer set up in trplicate
at 4 x UP cells/well in medum alone (B), PPD (P), or increasing doses of HEL.
The cultus wer pulsed with (3H)TdR for 6 hours at the end of a 96 hour
incubation. Symbols represent individual anmas, and the grup mean 
represented by a bar.
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with repeated low doses of OVA exhibit a maked reuction in the proliferative response to
OVA, as compar to T cells from untreated nonnal mice (left to right pc:0.OO1 , pc0.OO1
pc:.OO2). The unesponsiveness was antigen-speifc, because T cells frm both the
trated and untrated norm mice have comparable responses to PPD. As shown by the
panels on the bottom of Fig. 12, when B cell-deficient mice were trated with the sae
protocol, the T cell prolierative response to OVA was also reduced compar with the
untrated B cell-deficient mice (left to right pc:0.OO1, pc:0.OO3, pc:O.OO1). Therefore, B
cell antigen presentation was not reuied to induce T cell unesponsiveness following
repeate injections of low concentrations of OVA.
C. The Most Effective Dose for Tolerance Induction is 10 /lg OVAl. V.
Because my experients in the B cell-deficient mice indicated that B cells were not
reuied for low zone tolerance induction with repeated injections of 10 Jlg of OVA, I was
interested in determing whether reuiment for B cell antigen presentation would be
evident when lower doses of antigen were used to induce tolerance. Even though B cells
ar very effcient APC at low antigen concentrtions, it remaed possible that the 10 Jlg
Lv. dose of antigen used to induce tolerace was large enough for other AP to present the
antigen. Perhaps I could limt antigen presentation to B cells by reucing the dose of the
antigen given Lv. Firt I deterned whether I could induce tolerace, as measured by T
cell proliferative responses, by givig lower doses of deaggrgated OVA Lv. Norm mice
were given repeated injections of either 10, 1.0, 0. 1, or 0.01 Jlg OVA and then challenged
a week later with OVA in CFA. The proliferative responses of the LN T cells were
examned 10 days post-challenge. As shown in Fig. 13, tratment with 10 Jlg OVA was
the only dose that resulted in antigen-speific T cell unsponsiveness, as there was only a
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sma effect, if any, on the prolierative respnse to OVA in animals trated with repeted
injections of 1 Jlg or less of deaggrgated OVA. Since tolerce induction in norm mice
served as a contrl for expements peroned in B cell deficient mice, and I could not
measur tolerce in the norm mice with antigen doses lower than 1 Jlg OVA, I did not
attmpt to induce tolerace in the B cell deficient mice with lower doses of antigen.
CHTER V
SELECTIE T CELL UNRESPONSIVENESS FOLLOWIG
LOW ZONE TOLERANCE INDUCTION
The previous experients established that B cells were not reuir for tolerce
induction to low doses of protein antigens, as demonstrted by reuced T cell proliferative
responses in both nonnal and B cell-deficient treated animals. The ai of the next set of
experiments was to defme what other components of the imune response were
compromise by tratment with low doses of antigen. Was the B cell comparent affected
in the trate norm animals? What other T cell effector functions were comprmised by
the repeated low doses of antigen? I also wanted to exame the kietics of the proliferative
response in the trated anims, whether the antigen-specifc T cell proliferative response of
the trated anmas could be rescued with IL-2, and if suppressor T cells were present in the
LN cells reovered from the treate mice. The following experiments addess these
questions.
A. Antibody Production in Normal Mice Treated with Low Doses
of Antigen is Unaffected
Mitchison defied low zone tolerace in the 1960' s by showing that mice given
repeted low doses of soluble BSA had signcantly reduced antiboy prouction
following chalenge as compared to the untrated contrls (81). I decided to test whether
repeted low doses of OV A, in addition to causing a reuction in the proliferative responses
of the T cells, afected anti-OV A antiboy production in the nonnal anims. Fig. 14
shows the mean ELISA O.D. values for serum anti-OVA antiboy levels in the mice at 7,
14 and or 35 days after challenge. Anti-OVA antiboes were not detected in the
primune and prehalenge seru samples taen frm the untrted and trte anals
(Fig. 14 and data not shown). At day 7 the anti-OVA response of the trated mice was
slightly higher than that of their untrate littrmtes, indicatig that some of these anals
may beome slightly pred by the tolerace protocol. However, by day 14, the anti-OVA
antiboy prouction in the treated anmas was equal to that of the untreated mice (Fig. 14).
Anti-OVA antiboy production was the same in the treated and untreated anims in 
experients and was reduced about 2-fold in a fourh experiment, indicatig that the low
zone tolerace protocl did not reproducibly reuce helper T cell function or afect the B
cell comparent of the treate ans.
To determne whether tratment with low dose soluble antigen prouced a
qualtative change in T cell help, I examed the antiboy isotyps produced in the untrated
and trted nonnal mice. Nonnal mice were trated with the low zone tolerace protocl
and then chalenged with OVA in CFA along with the untreated controls. Thiry-five days
post-chalenge the titers of anti-OVA antiboy isotyps were determned by an isoty-
specfic ELISA, using mouse anti-phenylarnate antiboes of different isotypes as
stadars. The data presente in Fig. 15 indicate that the predomiant IgG subclasses
prouce by both the untreate and the treated mice were IgG 1 and IgG2b. Tota antiboy
in the untreate and treated norm anims was comparble. The preominance of IgG 
antiboy production and the near absence of IgG2a antiboy production by both groups of
nonal anmas suggested that the antiboy response may have been due to Th2-typ helper
cells (112, 113).
B Cell Antibody Production is not Affected
by the Low Zone Tolerance Protocol
-- 
=a_
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Figure 14. Six mice were trated with 10 Jlg OVA Lv. as in Fig. 12. The
untrte contrls and the trte mice wer then chalenged with OV A in CF A
in both hid footpad. Mice were bled weekly and serm anti-OV A titers wer
determed by ELISA. Seru was diuted 1:40, and 3-fold titrations are shown.
The open symbols represent the average of 6 individual serum samples frm the
untrated nor mice, and the closed symbols represent the average of 6
individual samples frm the trte mice. Diamonds represent preimmune
serum, trangles ar frm day 7;squares are from day 14, and circles ar from
day 35 post-challenge. The results ar representative of 3 out of 4 independent
experints.
Tolerized Mice Produce the Same Anti-OVA
Antibody Isotype as the Untreated Controls
1000
Untreated Treated
100
:1 I
II 1
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Figure 15. Six C57BU6 mice wer trated as in Fig. 12, and the trate
mice and the untrte contrls wer chalenged with OVA in CFA. Mice
wer bled 35 days post-chalenge, and an anti-OVA isoty-speifc ELISA
was perfonned. Each symbol represents an individual anma, and the mean
antiboy titers ar represented by bar. The results ar representative of 
independent experients.
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B. Th1 Cells are Compromised by the Low Zone Tolerance Protocol
Cyokie prouction by T cells from the trate anmas following stiulation with
OVA in vitro was examned in supernatats hareste at 24, 48, or 72 hours from primed
LN cultus frm untrated and trate nonal and B cell-deficient mice. The results of an
IF- spific ELISA shown in Table 1 indicated that the amount of IF- pruced in the
presence of PPD was unchanged between the untrated and treated mice, but the amount of
IF-yproduced by cells frm mice trted with deaggregated OVA was below the level of
deteon in both the trated norm and trted B cell-deficient mice.
The results of an IL-2 bioassay with the 1L- dependent cell line HT-2, shown in
Fig. 16, indicated that IL-2 production was also deceased in the supernatats taen from
the trate anmas, as expected due to the reuced proliferative responses. IL-4 was
undetecble (0: 0.78 U/ml) in the supernatats tested from the LN cells of either the norm
or B cell-deficient untrted or trated mice using the most sensitive bioassay for IL-4 (100)
(Fig. 17). Taken together, these results demonstrted that these in vitro proliferation
assays were primarly detetig a Th1 response, and that this Th1 response was reuced in
cells frm the trte norm and B cell-deficient mice, while T cell help for antiboy
fonnation was largely unafected.
Kinetics of the Proliferative Response in the Tolerized Animals
The peak of the T cell antigen-specific response may have been ealier in anims
exposed to low doses of antigen prior to chalenge, and this could result in reuced
prolifertive responses in these treated anims 10 days post-chalenge. To rule out this
Table 1
IFN -y (pg/ml) Production is Reduced in T Cells from
Treated C57BL/6 and B Cell-Deficient Mice
Anti en in vitro
Mouse str in vivo tratmen PPD OVA
C57BU6 untrte 10,900 :i 1124 881 :i 475
C57BU6 10 Jlg OVA Lv. 798 :i 530 -= 500
B cell-deficient untrted 23,961 :i 2867 20,697 :i 3855
B cell-deficient 10 Jlg OVA i. 13,422 :i 2507 -= 500
. C57BU6 and B cell-deficient mice were trated with 10 Jlg OV A i.v. the ties a week
for the weeks. The untrated and trated anims were then chalenged, and the drning
lymph node cells were harested five days later.
Supetats wer collected from whole lymph node cells stiulated with antigen in vitro
for 72 hr and tested in an IF-yELISA. These values were calculated on supernatats
taen frm the experiment shown in Figure 2A. The results ar representative of 
independent experiments, but the levels of IF- frm B cell-deficient mice were not
consistently elevated over those from norm mice.
1 SD.
IL-2 Production is Reduced in OVA-Stimulated
T Cells from Tolerized Mice
C578L/6
Untreated Treated
Dilution
100
Dilution
100
Treated
cell-deficient
Dilution
100
Untreated
Figure 16. C57BU6 and B cell-deficient mice were trated as in Fig. 12 and
chalenged with OVA in CFA along with the untreated contrls. Eight x 105
poled lymph node cells/oo ml were cultured with 
PPD (open diamonds), 100
Jlg/ml OVA (closed circles), or medum alone (open squars). lI -
2 proliferatio
is shown with supeatats collected at 24 hour from nonnal untrated and trate
mice (top) or untreate and trted B cell-deficient mice (bottom). The closed
trangles are the response of the lI-2 cells to .625 U/ml IL-
Dilution
100
IL-4 Production is Absent in Supernatants
from in vitro Stimulated T Cells
C57BL/6
Untreated Treated
Dilution
100
Dilution
100
cell-deficient
TreatedUntreated
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100
Dilution
100
Figure 17. C57BU6 and B cell-deficient mice were trated as in Fig. 12 and
chaenged with OV A in CF A along with the untrated contrls. Eight x 
poled lymph node cells/OO JlI were cultued with PPD 
(open diamnds),
100 Jlg/ml OVA (close circles), or meum alone (open squars). CI-
prolieration is shown with supernatats collected at 72 hour frm nonnal
untrte and trated mice (top) or untreated and treated B cell-deficient mice
(bttom). The close trangles ar the response of the CT -4S cells to 1.
U/ml IL-4.
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possibilty, I decded to examne the proliferative response of the T cells frm untreated and
treate animals at 5 and 7 days post-challenge. Norm mice were trated with the low
zone tolerace protocol, and then the trted and untrted mice wer chalenged with OV A
in CFA. As shown in Fig. 18, LN T cells from the untreated norm animas responded to
both PPD and OVA at both day 5 and day 7 post-chalenge. Interestingly, the response to
the lower doses of OVA in vitro was not seen at the earlier time point. This may suggest
that T cell afty for antigen incrses over tie after chalenge by selection of higher
afnity T cells (114). T cells from the trated mice had reuced proliferative responses to
OVA, but not to PPD, at both time points tested indicating that the reduction in
prolieration was not simply due to diferent kietics in the imune response of the trted
mice.
D. Addition of IL-2 in vitro Does Not Break T Cell Unresponsiveness of Cells
from Treated Animals
Next, I wished to test whether the reuction in the T cell proliferation obsered in
trate noral and B cell-deficient mice was the result of an inabilty of these T cells to
make their autoce grwth factor, IL- , in the in vitro assay (115, 116). Addtion of 1 or
10 U/ml ofIL-2 to the proliferation assay incrased both antigen-specific and backgrund
prlifertion in cells from untreated norm and B cell-deficient anims, but faied to
restor antigen-speifc proliferation to the treate norm or B cell-deficient anims (Fig.
19). For some unkown reason the overal T cell proliferative responses were low in this
experient, as shown by the proliferative response in the absence of exogenous IL-2. The
results frm this experient imply that the reduced proliferative response of the T cells to
T Cell Responses are Reduced Day 5 and Day 7
Post-Challenge in the Treated Animals
Day Post-challenge
125
Untreated Treated
100
10 100
J.g/ml OVA
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Figure 18. Nor mice were trte with 10 Jlg OVA Lv. and then chalenged
along with the untrate controls with OV A in CF A. Whole LN cells were
hareste 5 or 7 days post-challenge and set up at 4 x lOS cells/well in trplicate in
meda alone (B), PPD (P), or incrasing doses of OV A. Cultures were pulsed with
eHlTdR the last 6 hours of a 96 hour incubation. Symbols represent individual
anmals and the bar is the group average.
Addition of IL-2 in vitro does not Restore
Antigen-Responsiveness to Tolerized T Cells
C57BL/6
Untreated Treated
- ..---
-0"'
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Figure 19. C57BU6 and B cell-deficient mice were trated with 10 Jlg
deaggregate OVA i.v. 3 times a week for 3 weeks. Untrated and trate mice
wer challenged with OVA in CFA. T cells were pured 10 days post-chalenge
and cultu in trplicate at 6 x 105 cells/well with incrasing doses ofIL-2. Open
squas represent T cells cultu in medum alone, open diamonds reprsent T
cells in PPD, and closed cirles ar T cells incubate with 100 Jlg/ml OVA. T cell
proliferation was measur by (3H)TdR incorporation and shown here as cpm.
OVA frm the trate norm and B cell-deficient mice was not due to IL-2-reverible
anergy in vitro. This expeent did not, however, rule out the possibilty that the OV 
speifc T cells beam anergic in vivo and therefore were unable to expand propely upon
chalenge, resulting in fewer antigen-reactve T cells being reovere frm these animals.
E. Reduced Proliferative Responses are Not Due to the Presence of
Suppressor Cells in vitro
In other models of acquied tolerace, suppressor T cells have ben demonstrted
followig treatment with soluble protein antigen (117). I wanted to detenne whether the
presence of suppressor T cells in the trte anims might explai the reuced T cell
proliferative response to OVA. One way to test for the presence of suppressor T cells in
the pr LN cells from the trted mice was to mi T cells frm treated mice with equal
numbers of T cells from untreated mice, in order to determne whether the proliferative
response of the T cells frm the untrated animals was then reuced. To control for any
change in proliferation, due to only hal the number of pried T cells being present, T cells
frm mice pri with CFA were also mied with either untrated T cells or trated T cells.
Nor and B cell-deficient mice wer given the low zone tolerace prtocl, and trted
and untrted nonnal and B cell-deficient mice were chalenged with OVA in CFA. At the
sae tie a group of norm anims and B cell-deficient anmas were chalenged with
CFA alone. Lymph node cells were hareste 10 days after chalenge frm al groups of
mice and set up in vitro in the indicated combinations with PPD or OVA. The results of the
mixig experient peonned on T cells frm both norm and B cell-deficient mice 
shown in Fig. 20. Although the proliferative response of the nonnal animals was
r T
Cell Proliferative Responses are Unchanged
when Untreated and Treated Cells are Mixed
Normal Mice
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M 40
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Figure 20. Nonnal and B cell-deficient mice were treated as in Fig. 12. They
were challenged 7 days later with OV A in CF A with the nonnal and B cell-
deficient untrate mice. Another group of nonnal and B cell-deficient mice
were chalenged with CF A alone. Ten days later LN cells were hareste frm
al grups and set up in trplicate in medum alone (B), PPD (P), or OVA. Two
x 105 untrted cells were mixed with 2 x 105 treated or CFA-pried cells, and
2 x 105 trte cells were mixed with 2 x 105 CFA-pried cells. (3H)TdR was
added the last 6 hour of a 96 hour incubation.
somewhat low, and tolerace in both tys of animals was incomplete in this experient,
the OVA prolifertive respnse of the untrate T cells remaed the sam whether equa
numbers ofT cells frm CFA-primed or trated mice were added. Also, T cells from the
trate anmas mied with T cells from CFA-primed anmas remaed unrsponsive to
OVA. The sa pattrn of results was obsered with the dierent combinations of
untrate and treated T cells frm the B cell-deficient anmas. The results frm ths
experient provide no evidence for suppressor T cells in either the nonnal or B cell-
deficient trated anals.
, ,
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CHR 
MHC HALOTE-SPECIFC TOLERANCE
Durng my investigation into the role of B cells in self tolerce to the antigen HEL,
I mae the interestig observation that the induction of tolerce to the soluble self antigen
HE depended on the MHC aleles expressed by the trsgenic animals. These studies
were conducted with two trsgenic lines of mice on the C57BL/6 H-2b/ backgrund: ML-
4 mice had less than 0.5 ng/ml of HEL in their serum, and ML-5 mice that had 20 ng/ml of
serum HE (94). The HE trsgene was under the control of a metallothionein promoter,
and the trsgene-encoed self antigen HEL was constitutively expressed in both lines of
mice (94). As shown previously in Fig. 9, B cells were not reui to maintan tolerace
to HE on the H- bJk backgrund, as T cells from HEL-trsgenic B cell-deficient mice
were unsponsive to HEL following challenge with HE in CFA. Initially, tolerace to
the HEL self antigen in the absence of B cells was examed in H-2b1 B cell-deficient HEL-
trsgenic animals (data not shown). The surrising result from those experiments was
that T cells frm HE-trsgenic nonnal and B cell-deficient animals of the H-2b/
backgrund were responsive to HE. The experiments presented here addrss the
diferences in the T cell responses of the trsgenic H-
bJk F1 animas, which were tolerat
to HE, and the transgenic parenta strai H-2b/, which were not tolerant.
A. HEL- Transgenic H- b1b Mice are not Tolerant to HEL
The initial observation regardig the lack of tolerace to the self antigenHE on the
2b/backgrund was made when nontrsgenic and transgenic mice of the ML-4line
were prmed with HE in CFA, and the T cell proliferative responses were examned 10
days later. The results of four proliferation assays perfonned in nontrsgenic and HE-
trsgenic H- blb animas are shown in Fig. 21. The combined data in Figs. 21 and 22
were teste for signifcance using a genera mixed model analysis of varance. The
signcace of differences between individual pai of means were evaluated by paise
tests for prected cell means. I defined statistical signifcance as differences with a
probabilty under the null hypothesis of 0.05 or less. To compensate for the additive error
due to multiple comparsons, a Bonferonni adjustment was applied to get adjusted crtical
values that matain the nominal signficance. As shown in Fig. 21, the T cell proliferative
response of the transgenic animals to HE was significantly diferent than the response
observed in medum alone, demonstrating that tolerace to HEL was not established in the
transgenic H-2b/ animals. The difference in the T cell proliferative response to the antigen
HE between the nontrsgenic and trsgenic anmas reached significance, even though
the log means of the two grups were relatively similar, 9.94 +/- 1.31 vs. 9. 10 +/- 1.41
respetively.
The results of T cell proliferation assays perfonned in the H-2b/ HEL-trsgenic
anmas were different than those observed frm T cells in the HEL-trsgenic
animals as shown in Fig. 22. For these experiments, B10.A (H- ) mice were bred to the
ML-4 line on the (H- blb) background, creatig (B 1O.A x C57BU6) F1 
nontrsgenic and HE-transgenic animals. Mice of the H-2& haplotye express H-
MHC class n molecules. Nontrsgenic and transgenic mice of the t"& haploty were
prime with HE in CFA, and 10 days post-challenge lymph nodes were harested. The T
cell proliferative response to HEL of the trsgenic F1 H-2b1& anmas was not signifcantly
dierent than the response obsered in medum alone, indicatig that the HEL-speifc T
cells from H-2"'& trsgenic animals were tolerat to the HEL self antigen. Furennore,
1000
1 0
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Figure 21. Twenty-one C57BL/6 nontrsgenic and 22 ML-4 transgenic C57BU6
mice were pried with HEL in CFA in each hind footpad Ten days later the dring
lymph nodes were harested. LN cells were set up in vitr at 4 x loS cells/well in
trplicate in medum alone (Bgd), PPD, or HEL. Cultus were pulsed the last 6 hours
of a 96 hour incubaton with (3H)TdR. The results of 4 experiments are shown, and
individual mice within a single experiment are represente by the same symbol.
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Figure 22. Nine nontrsgenic and 9 HEL-trsgenic (B 1O.
A x ML-4) Fl anmals
were primed with HE in CF A in each hind footpad. Ten days later the popliteal lymph
nods were harested LN cells were set up in vitro at 4 x 
105 cells/well in trplicate in
medum alone (Bgd), PPD, or HEL. Cultues were pulsed with (3H)TdR the last 6
hours of a 96 hour incubation. The results of two experients are 
shown, and individual
mice within a single experiments are represented by the same symbol.
the T cell proliferative responses to HE frm nontrsgenic and trsgenic anmas of the
haploty were also signifcantly different, as shown by a large difference in the log
meas, 9.50 +/- .77 vs. 6.99 +/- .69 respectively. The T cell responses to the control
antigen PPD were comparble for both the nontrsgenic and trsgenic mice,
demonstratig that tolerace observed in the H-2"'. HE-trsgenic T cells was antigen-
speific.
It seems possible that the MHC molecules found in the two strns, H-2b/ and H-
2"' ., might have diferent affinities for the antigen HEL. Therefore, if the class II MHC
molecules in the H-2"'. str bind HE with a higher affinity than the class II MHC
molecules found in the H-2b1 strn, then tolerace would be induced at lower antigen
levels in the strain than in the H-2b1 strn. As shown above, the transgenic
animals were tolerat to the low levels of serum HEL, but the H-2b1 trsgenic animas
were not tolerat to HEL. I was intereste in determing whether tolerance could be
induced in the H-2b/ transgenic animas when serum levels ofHEL were increased, as ths
might promote bindig to lower affinity MHC molecules. To address this possibilty,
tolerace to HEL was examned in H-2b1 ML-5 transgenic anmas, which had much higher
levels of serum HE than the ML-4 trsgenic line, 20 ng/ml vs. c: 0.5 ng/ml. Higher
levels of HE in the ser did not result in tolerace induction in the H- 2
/D trsgenic
anmas, as shown in Fig. 23, beause T cells from both HEL-primed nontrsgenic and
ML5 HE-transgenic anmals were responsive to HEL, even though there was more
varabilty in the mean responses due to the sma number of anals tested.
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Figure 23. Thee nontrsgenic and 3 ML-5 HEL-trsgenic C57Bl)6 mice
were pried with 250 Jlg HE in each hind footpad. Ten days later the popliteal
lymph nodes were hareste and the cells were set up in trplicate at 4 x 105 cells!
well in medum alone (Bgd), PPD, or HEL. Cultues were pulsed with (3H)TdR
the last 6 hours of a 96 hour incubation. Symbols represent individual anmals.
B. The Presence of the H- Allele Confers Tolerance to HEL
Experients perfonned in the lab of Eli Sercar have shown that the C57BU6
backgrund is defective in the abilty to press HE into an imunodomiant peptide
capable of binding I- MHC molecules (118). Ths may be the reason that C57BU6 mice
have ben previously charcterize as low responders to the HE antigen (119). It was
unliely that the lack of tolerace observed in the trsgenic C57BU6 mice was due to an
inabilty to process HEL, beause (B 1O.A x C57BU6) F1 trsgenic animals, which have
simila backgrund genes to the C57BU6 anmas, were tolerat to HEL, demonstrting
that HEL had been efficiently processed and presented. It was possible that the differences
in tolerace induction observed between the parenta strai (H-
bJb) and the F1 anmas (H-
2b/8 were due to the presence of an MHC allele that could bind peptides ofHEL with a
higher affmity and prsent HEL peptides efficiently, therby inducing tolerace more
effectively. Adelstein and colleagues published that T cells from (CBA x C57BU6) F1 H-
ft transgenic mice were tolerant to HEL (94). As shown in Fig. 9, T cells from (BlO.
x C57BU6) F1 trsgenic animals were also tolerat to HEL. To confi the results of
Adelstein and colleagues, and to demonstrte that tolerace to the self antigen was observed
when the class n MHC molecules of the H- haplotype were expressed, I examned the T
cell proliferative responses of non trsgenic and transgenic (CBA x C57BU6) F1 H-2b1
mice. The results shown in Fig. 24 indicate that indeed T cells frm both (CBA x
C57BU6) F1 and (B 1O.A x C57BU6) F1 transgenic mice were unresponsive to HEL as
compar to their nontrsgenic littermtes. These results imply that the diferences
observed in tolerance to the self antigen HE between H- bJb transgenic mice and H-
transgenic mice was likely to be due to the presence of the MHC H- alele.
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Figure 24. Th nontrsgenic and trsgenic (CBA x C57BU6) F1 animals
and 3 nontrsgenic and 3 transgenic (B 1O.A x C57BU6) F1 animals were pried
with 250 Jlg HEL in each footpad Ten days later LN cells were hareste and set
up in trplicate at 4 x UP cells/well in medum alone (Bgd), PPD, or HEL. Cultus
were pulsed the last 6 hours of a 96 hour incubation with (3H)TdR. Symbols
reprsent individual animals and the bar indicates the mean.
C. Restricted Cells Dominate the Response to HEL in FI Animals
In an F1 anal it could be assumed that there would exist HE-specific naive T
cells restrcte to H-2\ others restrcte to H- , and some restrcted to H-
2b1. The
surrising result from my experients in HE-transgenic animals was that the H-
restrcte HE-speifc T cells frm trsgenic C57BU6 mice were responsive to HEL,
whereas in the F1-trsgenic anma neither the H- -restrcted nor the H- -restrcted
HE-speifc T cells responded to HE. To investigate whether H- -restrcted HE-
spefic T cells could be found in the immunize H-2b1 F1 animas, I decided to purfy the
T cells and examne the prolierative response to HEL presented by either H-
2b1 or H-
APs. (B10.A x C57BU6) F1-nontransgenic and F1-transgenic animals were primed
with HE in CFA, the lymph nodes harested, and T cells were pured 10 days post-
chalenge. The results of this experient ar shown in Fig. 25. The fit panel of both
grphs indicates that the T cell purcation protocl did not elinate al of 
the APCs frm
the LN T cells, beause T cell proliferation occured in the presence of 
PPD and/or HE in
the absence of any additional APCs. However, APs were limiting, beause additional
AP increased the response to PPD, and the addition ofH-'2 APC increased the response
to HE in the nontrsgenic animals. As shown in the top right panel of Fig. 25, the H-
restrcted HEL-speific T cells domiate the response to HEL in the nontrsgenic F1
animals, beause the T cell proliferative response to HEL increased when H-
2" APs
were added but did not increase when H-2b/ APs were added. The H- -restrcted HEL-
speifc T cells in the H-2b1 nontrsgenic animals did not respond in vitro above the level
observed in the absence of additional APCs, suggesting that they probably had not
expanded in the prime LN durng the challenge with HE. The T cells frm F1 
trsgenic animals were unrsponsive to HEL presented by either H-
/b or H-2" APCs as
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Figure 25. Five nontrsgenic and 6 transgenic (B1O.A x C57BU6) F1 ans
were pried with 100 Jlg HEind footpad, and 10 days later the lymph nodes were
harested Cells frm individual anmas were poled and the T cells were purfied
and set up in vitr at 4 x loS cells/well. Spleen cells from naive C57BL/6 or B 10.
mice were T -depleted irate and use as AP. T cells were cultued in trplicate
in medum alone (Bgd), PPD, or HEL. Cultures were pulsed with (3H)TdR the last
6 hours of a 96 hour incubation. Error bar represent 1 SD.
expete (bottom grph, right 2 panels). These results suggest that the tolerace observed
in the HEtrsgenic H- b/a animals could be due to deletion of the H- -restrcted HE-
speifc T cells.
The last set of experients adss whether H- -restrcte HEL-speifc T cells
could be detected in the transgenic F1 anmas when tolerace to HE was broken by
prig animals with a larger dose of HE in CF A. As demonstrted in the above
exprient, the H- -restrcte HE-specifc T cells domiate the response to HEL in the
nontrsgenic F1 anims; therefore it seemed liely that these T cells would be deleted in
the F1 HEL-transgenic animals. Thus, the respondig T cells recovered from F1
transgenic anmas primed with a large dose ofHEL may be H- -restrcte HEL-specifc T
cells that maaged to escape deletion. To addrss this possibilty, I primed 
nontrsgenic and trsgenic anims with a large dose of HEL and examed the T cell
proliferative response of these animals to the whole protein and to varous peptides of 
presented by H- "" H-2k/, or H- /k APCs. As shown in Fig. 26, the H- -restrcted
HE-speific T cells could be detecte in the transgenic F1 animas, beause, when H-
APs were added to pured T cells frm the F1-trsgenic animas, the responses to HEL
as well as to the H- -restrcted peptides, 30-53 and 74-88, were slightly enhanced (120).
The adtion of F1 APs also enhanced the response to HEL and the peptide 74-88, but the
2" APCs did not enhance the proliferative response of the T cells from the F1
trsgenic to neither HE nor the HE peptides. Even though the T cell response to 
and the HE peptides was quite low in the F1 trsgenic animals, the proliferative response
to the contrl antigen PPD was comparble for T cells frm both the nontrsgenic and the
trsgenic animas (data not shown). These results support my idea that the H-T-restrcte
T cells were probably delete in the trsgenic F1 animal, beause the H- class n MHC
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Figure 26. HEL-trsgenic F1 anmals were pried with 288 Jlg HEL/footpad, and
LN cells were hareste 10 days later. Pued T cells were set up in vitr in trplicate
at 4 x 105 cells/well with 2 x 105 irated T-deplete spleen cells as indicated. T cells
were cultu in medum alone (Bgd), 288 Jlg/ml HEL, or 7.5 JlM peptide. Cultus
were pulse with eH)TdR the last 6 hours of a 96 hour incubation. Err bar represe
1 SD.
molecules were likely to bind and present HE more effciently than the H- class n MHC
molecules, while the lower afnity H- -restrcted T cells escape deletion.
The T cell proliferative response of the nontransgenic F1 animals was priary
against the HE whole protein, with the cpm rangig from 71,097 to 105,143. As shown
in Fig. 27, the proliferative response of the F1-nontrsgenic T cells to the HE peptides
was comparble to the T cell proliferative response obsered in the F1 trsgenic anmas,
except that the proliferative response to the HEL peptide 20-35 was much higher, especially
when F1 APs were added Based on the results of the proliferation assay shown in
Fig.25, I would have expected a greater response from the T cells of the nontransgenic
anmas to the H- immunodomiant HEL peptide 46-61 (120). Because the T cell
response to ths peptide was very weak, the 46-61 HEL peptide may have been synthesized
incorrectly. There were two problems associated with the experient shown in Figs. 26
and 27 that ar most apparent in the HEL T cell proliferative response, as shown in the
legend to Fig. 27. Firt, the depletion of AP in the primed LN was incomplete, as T cells
from the nontransgenic anmas proliferated in response to HEL in the absence of APs.
The other problem was that the addtion of H-2b1 and H-2" APC to the purfied T cells
inhibite the proliferative response to the whole protein. However, it is useful to exame
these experiments, beause they provide an explanation for the tolerace obsered in the
F1-trsgenic anmals, and the results shown in Fig. 26 suppon other prelimnar fmdings
I had in the F1 HE-trsgenic anmas pried with a large dose of antigen.
In sum, when F1-nontrsgenic and F1-trsgenic animas were pried with
100 Jlg HEfootpad, it appear that only the high affmity HEL-specific T cells responded.
In the nontrsgenic F1 animals, the response was dominated by H- -restrcted HEL-
speifc T cells, and in the trsgenic F1 anals the HEL-specific T cells were
unresponsive, probably beause the high afnity H- -restrcted HEL-specfic T cells had
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Figure 27. F1-Nontrsgenic anmals were pried with 288 Jlg HEUfootpad, and
popliteal LN cells were hareste 10 days later. Pured T cells were set up in vitro in
trplicate at 4 x IOS cells/well with 2 x lOS inate T -deplete spleen cells as indicated.
T cells were cultu in medum alone (Bgd), 288 Jlglml HEL, or 7.5 JlM peptide.
Cutus were pulse with (3H)TdR the last 6 hour of a 96 hour incubation. Enr bars
represent 1 SD.
. r
ben delete. However, when higher doses of HEL in CF A were used for T cell priming,
the low affiity H- -restrcted HE-specific T cells were able to expand in the Fl
transgenic animal, and they were able to contrbute to the in vitro proliferative response
observed to both HEL and the peptides 30-53 and 74-88.
CHR VII
DISCUSSION
The way the immune system distinguishes between self and nonself has still not
ben clearly defined. The expeents presented in ths disserttion have addrssed '1111' 
whether antigen presentatio by B cells was reuir for perphera T cell tolerace to low
levels of self and foreign proteins. Experiments were perfonned in B cell-
deficient
anmas, and tolerace induction was measure by T cell proliferati
assays. Proliferation
assays in B cell-deficient mice indicated that B cells were likely to be involved in 
effcient
activation of naive T cells to protein antigen either 
in vivo or in vitro. 
Tolerace induction
in B cell-deficient anims was as effcient as in 
norm anmas, suggestig that antigen
presentatio by B cells in vivo was not required for tolerance to low levels of protein
antigen. The effect of tratment with low doses of 
deaggrgated antigen on the imune
response was also adssed. The data presented here 
demonstrted that repeated exposure
to low doses of deaggrgated OV A before chalenge inhibited the expansio
and
differentiation of antigen-specific T cells into Th1 effector cells in the 
dring lymph nodes
of the trted anals but did not afect the abilty of the antigen-specif
T cells to provide
help for antiboy fonntion following chalenge. The final set of 
experients presented
her suggests that the afnity of an antigen for an MHC molecule 
detennes not only how
well that antigen is presented to T cells, but also whether 
tolerace is induced to that
antigen.
4\:
Tolerance Induction Depends on Efficient Antigen Presentation
Durng the cour of my expements, I made the interstig observation 
that T cells
frm HE-trsgenic C57BU6 mice were not tolerat to low levels of a 
trsgene-encoded
self antigen HEL, but T cells from HE-trsgenic (BIO.
A x C57BU6) F1 animas were
tolerat to this self antigen, as shown in Figures 22 and 23. 
T cells from HE-pried
transgenic C57BU6 mice remaied responsive to HEL even when higher levels of the HEL
self antigen were expressed, as in the ML-5 line (Figu 24). The lack of tolerace in the
C57BU6 trsgenic anmas could be due to the inabilty of the I-
A b molecules in the
C57BU6 mice to bind HE detennants well enough to induce tolerace in the HEL-
specifc T cells. When antigen was given in adjuvant these HE-specifc T 
cells were
reveaed, because the HEL peptides were now presented at 
a higher concentrtion on APs
that also express high levels of both costiulatory and adhesion molecules, and 
the lower
afity T cells could be stimulated. C57BU6 mice have 
ben previously charcterze as
low responders to HEL in experients where anti-HEL antiboy 
responses were measur
following Lp. injection ofHE, whereas BIO.A mice were charcterize as 
high
responders, beause they were able to prouce anti-
HEL antiboes under the same
conditions (121). It was subsequently proposed that the T cells from HEL-
pried
C57BU6 mice were unable to provide help for B cell 
antiboy prouctio , beause these B
cells could not effectively process and present 
HE to T cells (122).
Experiments peonned in another line ofHEL-transgenic animals on the H-
background that express .c 2 ng/ml ser HEL 
provide an explanatio for the lack of
tolerance to HEL observed in the transgenic C57BU6 mice. 
T cells from the H- HE-
transgenic animals were responsive to HEL 
in vitro and also responded to the HEL peptide
103-117, a 15-mer that encompasses the imunodominant detennant of HEL in 
this
str, 108-116 (123). They proposed that in the trsgenic anmals the high afnity TCR
for HE have ben eliate while the low affInity TCR remain responsive to HEL in the
pephery upon chalenge. Additional evidence in favor of this explanation was
subseuently provided when they demonstrted that the V Ii reperoirs of the nontransgenic
and trsgenic animas were quite diferent (124). In H- anmals the response to HE is
domiate by one peptide, 108-116, and in the nontransgenic anmas a predominant TCR
, '
rearangement was found. However, in the HEL-trsgenic anmals this reargement
was absent, and each trsgenic animal had unique TCR remangements that recognized
HE. In the nontrsgenic anmas, unique TCR reargements were also identified that
vared frm anim to anal, presumbly recogniing deterants other than the e '
e "
imunodominant HEL peptide 108-116. Therefore, it is possible that in the C57BL/6
transgenic mice the high affInity HEL-specifc T cells were deleted in the thymus, and the
in vitro T cell proliferative response I obsered after priming with HEL in CF A was due to
low afnity HEL-specifc T cells found in the periphery.
Tolerace induction to the trsgene-encoded HE antigen was found to corrlate
with the presence of the H- allele, because T cells from transgenic animas with both H-
and H- MHC class n molecules, (B IO.A x ML4 C57BL/6) F1 and (CBA x ML-
C57BU6) F1, were unrsponsive to HEL. These results provide evidence that the HEL
antigen was prsented effciently by H- MHC molecules; therefore tolerace was
I' e
established, at least for the H- -restrcted HEL-specific T cells. Since a concentrtion
thshold exists for deletion of autoreactive T cells in the thymus, the haplotye of the
MHC could affect the thshold for tolerace induction dependig on how well it could
bind certn peptides. Therefore, in the H- /b animas, the H- MHC molecules might be
unable to bind and present a high enough concentrtion of HEL to induce deletion of the
autoreactive cells, whereas in the Fl anmas the H-T MHC molecules might bind 
- -- - - - , .. . ----' ' --- '-- - --
with a higher affiity and present low levels of this antigen effciently enough to induce
deletion of the HE-speific T cells.
In light of the fidig that the T cells frm the transgenic C57BIj6 parnta str
were responsive to HE, it was surrising to find that the HE-specific T cells were
tolerat in the trsgenic F1 anmas, beause in an F1 anim there should have ben some
HE-speifc T cells restrcted to H- , others restrcte to H- , and some restrcted to H-
2b1. If the H- -restrcted T cells domiated the response to HEL in the F1 nontrsgenic
anals, as discussed above, then in the F1 trsgenic animals the H- -restrcted HEL-
spec T cells would be deleted, and the response frm the H- -restrcted T cells should
have ben more apparent. As shown in Fig. 26, the H- -restrcted HEL-specifc T cells
could be detected in the trsgenic F1 anmas, but only after a large dose of antigen was
use for T cell primig. These results would be consistent with the idea that the 
HE-
speifc H- -restrcte T cells were of lower affinity; therefore more antigen was reuir
to elicit their response.
Ther ar at least the possibilties to explain why the H- -restrcte HEL-speifc
T cells do not respond to the nonnal antigen dose in the transgenic F1 anmas, but do
respond in the H-2b/ animals. The fIrst possibilty has ben refened to as detennnant
snatching. If the H- MHC molecules have a higher afnity for HEL than H-
MHC
molecules, then HE peptides may not be presented to H- -restrcted HEL-specifc T cells
in the F1 anmals, beause HEL preferentially binds and is proessed on H-
MHC
molecules. Support for deterant captur as a mechansm of detennnant selection has
come frm the labotory of Eli Serar after analyzing the prsentation of HEL in
nonobese diabetic (NOD), (NOD x Balb/c) Fl, and E trsgenic NOD mice (125). They
found that the presence of the E molecule, which binds the domiant detennnant 108-
116,
in the F1 anmas eliminate the response to the adjoinng peptide detennnant 95-102,
which is nonny sen as a subdominant detennnant in NOD mice. Another 
explanation
for the tolerace to HE obsered in the F1 transgenic animas is that the presence of H-
may have an effect on the H- T cell repertoire. It is possible that a self peptide 
presente
on H- MHC molecules could cause deletion of the H-
-restrcted HEL-specifc T cells.
An adtional possibilty is that when negatve selection of the high 
afity H-T-restrcte
HEspefic T cells occur, very low afnity H-T-restrcted HEL-specific T cells might
escape deletion. These low afmity H- -restrcted HEL-specifc T cells could 
develop into
Th2 effector cells upon encounterig HEL presented by APC following challenge with
HE in CFA, as it has been shown that peptide/MC class n complexes that interact
weaky with the TCR favor primig of Th- lie cells 
(126). These low affinity H-
restrcte HEL-specifc Th2 cells would not proliferate 
in vitro upon antigen stiulation,
but could suppress the response of the H- -restrcted HEL-specifc T cells.
B. Are Cells Necessary for in vivo 
Priming of Naive 
Cells?
The fIrst set of experiments presented in this thesis addressed whether activated B
cells could stimulate unpried naive LN T cells. These experients were perfonned 
in B
cell-deficient anmas, crated by the tageted disrption of the 
Jl heavy chai, and the
fidings indicated that there was a defect in the abilty 
of T cells to prolierate 
in vitro
following prig in vivo in the absence of B cells. I found that the 
overa proliferati
response of whole LN cells from the B cell-deficient anmas was 
consistently 3 to 10-fold
less than in nonnal animals (Figu 3). This defect was fIrst reported in animals made B
cell-deficient by anti-Jl tratment (102). Over the year, many investigators have addrssed
the role of B cells in stimulating T cell responses. Severa possibilties have 
ben
suggested: B cells may be reui for prig naive T cells in vivo (102-105), B cells may
contrbute in vitro as antigen-speifc APC for T cells (101, 108), the antiboy prouced by
B cells may contrbute to macrophage prming ofT cells (105), the fonn of the antigen 
may
be importt in detennnig which AP is reuired to initiate T cell responses (127), and
fialy non- AP may initiate T cells responses, but B cells may be necessar forT cell
clonal expansion (103, 105). Mter noticing the deceased abilty ofT cells from B cell-
deficient mice to prlierte in vitro following antigen prg, I also became intereste in
detennning which, if any, of these possibilties were corrt.
The abilty of activated B cells to stiulate naive T cells has ben ver
contrversial. As mentioned above, the basis for the idea that B cells were 
importt for
initiatig T cell proliferative responses stemmed from the fmdig that T cells from protein
pr anti-Jl trte mice prolierated poorly when restimulated in vitro with antigen.
Although my own experiments supported this finding, experiments perfonned in 
SCID
mice demonstrated that B cells were not reuir for efficient T cell prig. Sunshie and
colleagues found that when 
SCID mice were trsfused with adult thymocytes, and
subseuently pried with the protein antigen KLH, the T cells proliferate and secreted IL-
2 (106). Ronchese and Hausman also demonstrted that T cells could be efficiently
prime in the absence of B cells by reconstitutig SCID mice (H- ) with either F1 (H-
2b/d
T cells alone or F1 T and B cells (107). They found that the MHC restrction of al the
responding T cells was H- , indicating that the T cells had been primed by the 
dendrtic
cells of the host, not the F1 B cells.
However, additional evidence in support of the idea that B cells were involved in
intiatig the imune response in the LN was demonstrted by Ron and Sprent when they
report that the addition of B cells subcutaeously into anti-Jl treated mice, prior to
injection of antigen, restore the T cell proliferative response (103). This was also shown
by Kur-Jones and colleagues when hapten-pried B cells were injected into anti-Jl 
trted
mice together with haptenate antigen in CFA (105). As shown in Figur 4, when I
injecte T -deplete spleen cells into B cell-deficient anmas, the T cell proliferave
responses were paraly restored in only some of the anmas. The difference between my
findigs and those of Ron and Sprent could have been the soure of B cells, beause I use
T-deplete spleen cells, and they used B cells purfied frm lymph nodes. Alternatively,
antigen-speifc B cells may enhance the T cell prolierative response by presentig antigen
more effciently in vitro than other APC.
Indeed, evidence that B cells contrbute in vitro to the T cell proliferative response
as antigen-spefic AP was reported by Malynn and colleagues after discoverig that
SRBC-specifc T cell proliferation reuied the presence of primed SRBC-specific B cells
in the in vitro cultues (108). Furennore, Epstein and colleagues (101) found that the T
cell proliferative response of noral and B cell-deficient anims was equivalent only when
B cells were rigorously removed frm the primed T cells by including anti-B220 in their
purcation scheme, suggesting that contaatig B cells in the T cell prepartion could
have contrbuted to the proliferative response by acting as antigen-specific AP in vitro. 
my own experients, the proliferative response of OV A-pried T cells from B cell-
deficient mice was not enhanced by the addition of either OV A-pried B cells or non-
specific B cells, as shown in Figure 5. However, the results shown in Figur 6 indicate
that when T cells were pured frm both the norm and the B cell-deficient mice, the T
cell prlierative responses of the nor and B cell-deficient mice were mor comparble
when the T cells were set up at lower cell densities in vitro. In other experiments, B cell
depletion in vitro did not bring proliferative responses of norm mice down to the levels of
B cell-deficient mice, but it is possible that my B cell depletion was not always as complete
as that of Epstein and colleagues, even when I used anti-B220 to deplete.
There is also expenta evidence suggestig that cirulatig imunoglobuln
may enable macophages to function as antigen-specifc AP. Kur-Jones and colleagues
reonstituted anti-Jl-treate Fl anals with parnta FlC-specifc B cells frm nonn
mice, prmed either 2 weeks or 4 months earlier, and examed the MHC-restrction of the
repient T cells afr chalenge with FlC-OV A in CFA (105). The primed T cells in the
anti-Jl tred anmas renstitute with FlC-specifc B 
cells trsferr 4 months afer
donor prig were restrcted to recognzing antigen on APC of the same haploty as the
trsferred B cells. However, when FlC-specific B cells were 
transferr two weeks
after donor priming, and therefore could probably continue to produce 
antiboy, the
responding T cells were able to recognize antigen presented by both the F1 APC as well as
the parenta AP. Thus, the antiboy produced by the donor B cells after challenge in the
reipient anti-Jl trated anmas may have ben bound by the host macrophages, enabling
them to prsent antigen to the T cells.
Recent experients peonned in the lab of Ki Bottomly have indicated that the
fonn of the antigen dictates which AP preferentially primes CD+ T cells. On the basis of
expements using mice that express I-E on different APC or mice that are B cell-
deficient,
they concluded that dendrtic cells were the most effcient APC for 
prig T cells to
peptide antigen, whereas B cells were necessar for T cell 
prig to whole protein (109,
127). My own experiments were not entily consistent with their fmdings. The results
shown in Figue 7, comparng pring with PCC peptide vs. PCC whole protein indicate
that in the absence of B cells, prig with peptide was more effcient, but this finding may
depend more on which antigen was used. In thee experiments I perfonned, the T cell
proliferative response of the nonn animals to the protein antigen PCC was consistently
lower than their response to the protein antigen OV A (Figus 3, 7, and data not shown).
Furennore, Constat and colleagues showed that there was a grater difference 
between
the T cell proliferative responses of nonnal and B cell-deficient mice primed with PCC
protein (6-fold dierence) than pred with OVA protein (less than 2-fold dierence)
(127). Therefore, it may appear that peptide prig results in bettr T cell responses when
B cells are absent, but this may just depend on which protein was used in the experient,
PCC or OVA. The best way to adss whether dendrtic cells or B cells preferentially
present peptide or protein antigen, respectively, would be to prime normal and B cell-
deficient mice with a varety of different antigens in the fonn of peptide antigen and protein
antigen and then exame the T cell response in vitro.
The results of my own experiments, as well as those of others, have not completely
resolved the role of B cells in priming naive T cells to antigen. CUlTntly, the general
thinkg is that dendrtic cells, due to their constitutive expression of high levels of
costimulatory activity, probably initiate T cell responses, while activated B cells can drve T
cell clonal expansion (128). Evidence that dendrtic cells stiulate naive T cells has been
shown in vitro using naive T cells from trsgenic animas. Trasgenic T cells that
reogniz a peptide of PCC were found to proliferate and produce IL-2 when antigen was
presented by either dendrtic cells or activated B cells, but at lower cell numbers dendrtic
cells were better stimulators of naive T cells (129). Dendrtic cells might be superor APC
for naive T cells at lower cell numbers, because they express higher levels of costiulatory
actvity than activated B cells (130).
The idea that B cells can promote T cell clonal expansion and diversifcation of the
T cell response once the T cell has ben initialy activated by dendrtic cells cOlTlates with
B cells ' unique antigen-specifc AP capabilty. A single protein antigen could be captur
by a varety of B cells with different antigenic specifcities; thus a unique ary of peptides,
including domiant and subdomiant determnants, would be generated in each B cell and
presente ver effciently, depending upon where the bindig site of the immunoglobulin
molecule was located on that protein (131). Support for this idea comes from experients
in which the injection of a single imunodomiant peptide frm the autoantigen MBP not
only reulte in the development of EA but was also able to generate T cells that wer
respnsive to other peptides withn MBP (132). Similar exprients perfonned in B cell-
deficient mice should demonstrte definitively whether B cells ar reui for expansion
and diversification of the immune response.
C. B Cells as Tolerizing APC to Low Doses of Antigen
The next set of experiments presented in this thesis addressed whether B cells were
reuired as antigen-speifc APC in tolerace to low concentrations of soluble self proteins
or in acquired tolerace to low doses of a foreign protein antigens. There are severa
resons for proposing that B cells would be involved in tolerace induction to low
concentrations of soluble protein antigens. B cells ar ver effcient AP, due to their cell-
surace imunoglobulin receptors, and can pick up antigen at 1O,OO-fold lower
concentrations than other non-specific AP (39, 57, 133, 134). Therefore, antigen-specific
B cells might be the only AP in the periphery that could captu enough of a low dose
antigen to afect a T cell response. Also, B cells have been shown to proess and present
monovalent antigen while remaing in a restig state (135). It has ben well established
that T cells reuir two signals frm an APC to beome fully activated, antigen regnition
and costiulation, and since restig B cells lack costiulatory activity it seemed liely that
they would present antigen in a tolerogenic maner to a naive T cell. Furennore, several
studies have shown that naive T cells cannot be activated by restig B cells (129, 136, 137,
138). In addition, our laboratory and others have shown that small resting B cells can act
as potent tolerig APC for matu perphera T cells (87-93). Therefore, I used B cell-
deficient anims to diectly test whether B cells wer involved in tolerance to low
concentrtions of soluble self proteins and in acquir tolerace to low dose soluble foreign
protein antigens.
To look at tolerce to soluble self proteins in the absence of B cells, B cell-
deficient mice were created that expressed a trsgene-encoded self antigen, HEL, at low
levels in the seru (Figu 8, and 94). I found that self tolerace, as measur by 
reuction in HEL-specifc T cell proliferation, was intact in the ML-4 HEL-trsgenic, B
cell-deficient anmas, as shown in Figu 9. There ar at least two possible explanations
for ths result. Perhaps some other APC can present HEL suffciently well to inactivate the
HEL-speifc T cells in the perphery, despite the extrmely low serum concentrtion of
HE. Alteratively, the HE self antigen may have been presented in the thymus resultig
in the deletion of the self-reactive T cells durg development. Although my own
experients could not distiguish between tolerace induction occurg in the thymus or
the periphery, in H-2b1ML-5 mice, which express higher levels ofHEL in the serum than
ML mice, tolerace to HEL was shown to result frm thymc deletion of a high afnity
HE-specifc TCR (111 and C. Gooow, personal communication).
The second system I used to examne tolerance induction by B cells was 
acquir
tolerce. In acqui tolerace, prior exposur to an antigen under cert conditions will
result in antigen-spefic nonrsponsiveness when the antigen is later given in an
imunogenic fonn. The experients on acquir tolerace in the 1960's demonstrted that
deaggrgated antigen, given either Lv. or Lp. in repeated low doses or one high dose,
resulted in tolerace induction using antiboy fonnation as a readout. I found that low
zone acquired tolerance could also be measured by T cell proliferation assays. 
As shown in
Figues 10 and 12, nor mice given repeate injections. of deaggrgated antigen Lv. were
rn-
found to have reuced T cell proliferative responses following chalenge with antigen in
CFA. The results in Figue 13 suggested that the antigen dose used for tolerace induction
was importt, as T cell responses were not inhibited in anmas pretreated with doses of
antigen of 1 Jlg or less.
The results shown in Figu 12 demonstrted that acquir tolerance to low dose
foreign proteins also was shown to occur in the absence of B cells, as both norm 
and B
cell-deficient anmas trted with low doses of OV A exhbited a reuction in antigen-
speific T cell proliferation and IL-2 production and in a loss of antigen-specifc IF-
proucton following challenge. Recently, B cell-deficient mice have been used to show
that B cells ar also not requi for high zone tolerance to protein or peptide antigen or for
superatigen-induced T cell unrsponsiveness (139-141). These findings on self and
acquir tolerce in B cell-deficient mice do not rue out the possibilty that ther may be
other conditions under which antigen-specific B cells ar requied for tolerace induction.
Instead they indicate that other APC in the periphery must be able to present both high and
low concentrtion antigen to immunocmpetent T cells in a tolerogenic maer. 
Recntly,
macrphages that have differntiated in the presence of macophage colony stimulatig
factor have ben shown to be able to induce antigen-specifc apoptosis of peripheral T cells
(142). It has also ben shown that even dendrtic cells, nonnaly thought to be
constitutively high for the expression of costiulatory molecules, can be tolerogenic 
for matu perpheral T cells when antigen is tageted to them (F. Finkelman, submitted).
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D. What is the Effect of Low Doses of Antigen on the Resulting
Immune Response?
In the coure of these experents, I found that paral low zone tolerace appear
to have a selecve effect on the Th1 response, as measured by a reuction in antigen-
speific proliferation and loss of IF-yproduction in vitro, without a correspondig loss in
the abilty to mae a high titer IgG 1 and IgG2b antiboy response to this T -dependent
antigen following chalenge with antigen in CF A. Acquied tolerance to low doses of
foreign protein antigen was origialy defied by Mitchison (81) by measurig antiboy
fonnation to BSA. He was unsuccessful at inducing low zone tolerance, measure by
antiboy fonntion, with the antigens OVA or HE, and found instead that these antigens
immunized the trated animals at very low doses, down to 0. 1 Jlg (143). As shown in
Figur 14, I confied that low doses of deaggregated OV A do not prevent antiboy
responses following challenge with OV A in adjuvant, although none of my mice made an
antiboy response before challenge. Instead, I found that Mitchison ' s low zone tolerace
protocol with OVA resulted in T cell unresponsiveness in the LN proliertion assay and
loss of IF-y production.
Because the trate mice mae the same amounts of the same IgG subclasses as the
contrls in most experiments (Figu 15), it seems liely that both the B cell comparent
and T cell help for antiboy fonnation were not affected by tratment with deaggrgated
OVA. The lack of an effect on the B cell companment was expected. There ar dierent
dose reuirments for inducing tolerace in the B and T cell comparents: lower doses of
antigen compromise the T cell comparent, but higher doses of antigen ar needed to
inactivate the B cells (94, 144). The selective loss of the LN T cell proliferation response is
harer to explain. It may reflect merly a dierence in sensitivity of T cell proliferation
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versus help for antiboy formtion; perhaps T cell help is not limting for antiboy
formtion at the level of T cell tolerace that was achieved. A more intersting possibilty is
that exposur to low dose antigen in the absence of adjuvant reuce the abilty of OV A-
speifc T cells to dierntite into Th1 effector cells capable of mang IF-yor the large
amounts of IL- requir for the LN proliferation assay. Since neither IL-2 nor IF-yare
necessa for T-dependent antiboy fonnation (145, 146), the antiboy response was
relatively unafected. Attenuation of a future Th1 response, parcularly prouction of the
proinfamatory cytokie, IF-y, could be an appropriate response to low dose antigen in
the absence of infection or tissue dage in order to limit imunopathological responses to
proucts of commensal microorganisms or environmental antigens.
The attenuated Th1 response could result frm a shift in prouction frm Th1 
lilli,!'
Th2 cytokies in the low dose OV A-treated animals. Guery and colleagues recently
repoed that contiuous adnistration of low dose soluble proteins to Balb/c mice using
mii-osmotic pumps suppresses subsequent Th1 cytokine prouction while prig
strngly for Th2cytokies (147). Enhancement of Th2 cytokines was previously reported
in paral high zone tolerace to huma IgG (148-152). Th2 cells would be expected to
retan helper function for the antiboy response, but lose the abilty to proliferate
vigorously and mae IF-yupon restimulation in vitro. Th1 and Th2 cells secte
mutualy inhibitory cytokies which cross regulate each other (63). This cross regulation
tends to tip the imune response towars cell-medated or humora imunity, respectively
(13, 153). Recently published experents have shown that stimulation of naive T cells
with low or very high doses of antigenic peptide 
in vitro promotes the development of Th2-
like cells, regardless of APC tye (154, 155). However, in my experiments, I was unable
to detect prouction of the Th2 cytokie, IL-4, by LN cells from treated animals or
untrated contrls. This may be due to the C57BU6 background, which has been
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associated with low IL-4 prouction (147). On the other hand, high levels of IgG1, which
ar charctestic of antiboy responses drven by Th2 cells (113), were produced both in
anmals trate with low doses of antigen and in the untrated contrls. Therefore, I have
no evidence for or against an effect of low dose, deaggrgate antigen on a subsequent Th2
response. It is not clear frm the high zone tolerance experients mentioned above that
Th cytokies ar necessa for inhibition of the Th1 response (149). It may be just that
the Th1 response is more sensitive to tolerizig treatments, so that paral tolerace spars
the Th2 response (156). In fact, Romball and Weigle have shown that tratment with a
high dose of deaggrgated huma IgG, under conditions which induce more complete
tolerace, as measur by antiboy fonnation, results in tolerace of both T helper subsets,
It should be noted that none of my mice made antiboy before challenge in response
to repeated injections of 10 Jlg of deaggrgated OVA, and only 6 of 16 mice showed barely
measur by IL-2 and IL-4 prouction (156).
detetable prig for an ealier antiboy response following chalenge with OV A in
adjuvant. Therefore, the selective loss in the abilty of treated mice to mount a Th1
response occur silently, and seems unlikely to be accompanied by a lot of clonal
expansion and prouction of memory or effector cells.
What is the Mechanism of Tolerance Induction in Selective
Low Zone Tolerance?
As shown in Figue 18, the T cell proliferative responses of the treated anmas
were also reuced at earlier time points post-chalenge, at day 5 and day 7, suggesting that
the unrsponsiveness obsered 10 days post-chalenge was not simply due to a change in
the kietics of the response in the trated anmas. I also found no evidence that the
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antigen-reactive cells had migrted into the spleen following Lv. admistrtion of antigen,
as the splenic T cell proliertive response of the treated animals were also reduced (Figu
11). Due to the low fruency of antigen-specific T cells in my animals, I am unable to
follow the fate of the antigen-specific T cells in the periphery after the treatmnt with low
doses of antigen. However, Kearey and colleagues used TCR trsgenic T cells
adoptively trsferr into syngeneic reipients to follow the fate of a few antigen-reactive
T cells when antigen was given s.c., Lp., or Lv. (157). They found that antigen
adistered s.c. in CFA led to the proliferation and persistence of the antigen-specific T
cells in the LN, and these cells remaned responsive to restimulation with antigen severa
weeks later. Antigen given i.v. or Lp. also caused initial proliferation of antigen-reactive T
::1111
:1111111
cells, but then most of these cells disappear frm the lymphoid tissues, and the remaing
cells were unrsponsive. They proposed that the antigen-specific T cells could not be
111111,
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detected in the LN, because they had migrted to the gut-associated lymphoid system where
they died, or they may have undergone activation-induced cell death in the LN, or perhaps
ilill
they were unable to prouce adequate levels ofIL-2 which resulted in apoptosis induced by
grwth factor withdrwal.
There ar at least two addtional mechansms that may account for the reuced T cell
proliferative responses following treatment with low doses of deaggrgated antigen:
suppression or anergy. Suppression has previously been implicated in high zone tolerance
to huma y globulin. Spleen cells from tolerat mice adoptively trsfer into irate
recipients were shown to suppress an antiboy response (158-160). However, Gahng
and Weigle reported that suppressor cells were not responsible for the reuced T cell
proliferative responses they found in mice that were tolerat to human y globulin (161). I
also found no evidence for suppressor T cells in the treated, chalenged animals, beause
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the norm prolierative response to OVA was not reuced when equal numbers of T cells
frm the trated and untrated anims were aded together (Figu 20).
There ar two interactions that have been reported to give rise to anergy. The fit
has ben well established using Th1 clones, and was shown to result frm T cell reeptor
reognition of antigen in the absence of costiulation (45). If exogenous costiulation
was provided durg the initial TCR reognition of antigen, then anergy was prevented.
Costimulation promotes the production of the T cell autoce grwth factor IL-2 (60, 61).
When T cells become unrsponsive, due to the induction of anergy, they are unable to
prouce IL-2. Furennore, it has been reported that addition of exogenous IL-2 to the
unrsponsive T cells wil reverse T cell clonal anergy. Jacobs and colleagues found that
high zone tolerace, as measured by T cell proliferation, could be reversed by addition of
exogenous IL- in vitro, suggesting that the mechansm of tolerance induction in their
model was anergy of the antigen-specific T cells (116). However, as shown in Figue 19,
I found that the addition of exogenous IL- in vitro faied to reveal an expanded population
of anergic, antigen-responsive cells in the challenged LN of the trated anmas. One
possibilty for the diference in our findigs could be due to the amount of IL-2 added to
our in vitro cultures. Exogenous IL2 may have been a limtig factor in my experiments,
as the T cell prolierative response in the presence of 10 U/ml IL-2 was still not at a plateau.
Therefore, I canot completely rule out anergy as the mechansm for the T cell
unrsponsiveness in low zone tolerance because the T cell response may have been restor
if higher concentrations of IL-2 were added in vitro. It is also possible that the OV A-
speifc T cells had beome anergic in vivo, but did not expand upon chalenge, which
would result in fewer antigen-reactive T cells being recovered frm these anmas.
Experients perfonned in the lab of Paul Allen have established the secnd
interation tht will result in T cell anergy. Their experments demonstrated that the
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presntation of alter peptide ligands to T cell clones would result in antigen-spefic
unrsponsiveness to subsequent stimulation with the immunogenic peptide (162). Altere
peptide ligands dier frm imunogenic peptide ligands in the residues that interact with
the TCR. They propose that when T cells regnize the altered peptides on MHC
molecules that they beome paraly activated These alter peptide ligands may interact
with lower afmity with the TCR than the norm imunogenic peptide, resultig in only a
paral signal being trsducoo from the TCR. Ths may be due to an inabilty of the
peptidelMC complex to cause a change in the TCR. Perhaps the MHC/peptide!ICR
IIw:lrii
interaction is shor-lived, or there may be no association of required surace molecules with
the TCR. Unlie the T cell anergy that is induced when peptide is recognized in the
absence of costimulation, anergy induced by ths interaction cannot be prevented by the ill,
adtion of exogenous costiulation (163). They studied the presentation of altere peptide
ligands to both Th1 and Th2 clones and found that anergy could be induced in both CD4+ T
cell helper subsets (163, 164). Th1 clones that had been exposed to altere peptide ligands
failed to proliferate and were unable to prouce IL-2 or IF-y upon stimulation with the
imunogenic peptide (163). Anergy induced in Th clones by this paral activation also
resulted in a loss of proliferation, but unlike anergic Th 1 cells, the anergic Th cells
retaned their abilty to prouce cytokines upon restiulation (164).
It is interesting to propose that treatment with low doses of deaggrgate antigen, in
the absence of adjuvant, may affect the respondig T cells in a maer simiar to an altere
peptide ligand In addition to the afnity of the TCR for its peptide ligand, perhaps there is
also a concentrtion thshold so that the tota numbe of peptide/C complexes
interatig with the TCR is also crtical for a noral signal to be delivered upon TCR
engagement. Even though there might be fewer peptidelMC complexes fored on 
AP when low doses of antigen ar given in adjuvant, an immune response would be
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induced beause costiulatory molecules and adesion molecules would be upregulated
alowig a productive and long lastig interation to occur between the AP and T cell. In
the absence of adjuvant, the level of cell-surace costimulatory and adhesion molecules on
the AP would be less; therefore the T cell may only get a paral signal frm antigen
reogntion beause it dissociates more rapidly frm the AP.
My fidings in mice trated with low doses of peptide ar simar to the fmdings
observed when T helper clones ar presented with altere peptide ligands. Treatment with
low doses of antigen followed by chalenge with an imunogenic fonn of antigen resulte
:111111,
in reduced proliferative responses and a reduction in IL-2 and IF-y production. Although
I was unable to detect IL-4 prouction in vitro, the presence of OVA-specific IgG1 in the
!III'
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trate anals suggested that the Th cells were not compromised in their abilty to secte
IL-4. Therefore, pehaps the phenomenon of low zone tolerace cannot be explaied by a
Ill
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speial AP that would present antigen in the absence of costimulation, but instead diectly
corelates with the antigen dose, and the way in which the resulting peptidelMC
III,
complexes that ar fonned eventualy interact with the TCR.
F. Summary and Future Directions
This thesis provides evidence that tolerace induction to low levels of antigen can
ocur in the absence of B cells. Self tolerace to a transgenic self antigen, HEL, in a strn
with very low levels of serum HEL was found in both norm and B cell-deficient
transgenic anmas. Also, nonnal and B-cell deficient anals trated with repeated low
doses of deaggrgated OV A had reuce in vitro T cell proliertive responses upon
chalenge with OV A in CF A. The in vitro T cell proliertion assays wer prily
detectig a Th 1 response, and tolerace following treatment with deaggrgated low dose
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OVA was selective for this response, beause the production of IL-2 and IF-y was
reuce in cells frm the trated nonn and B cell-deficient mice. The antiboy response
of B cell-sufcient mice to ths T cell-dependent antigen was largely unafecte by the
tratnt, as both trte and untrte ans pruced equivalent titers of anti-OVA
antiboy, predominantly of the IgG 1 and IgG2b isotypes, following chalenge with OV A
in CFA. In experents perfonned in HEtransgenic animals of two different haplotys,
the efficiency of antigen presentation was also shown to be importt in tolerace
induction.
IIIIIII!II,
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i111My results contrbute to the evidence in the litertue that antigen dose is intitely
involved in the development of either Th1 and Th2 effector cells (154, 155). Antigen dose 111111
probably relates to the level of peptidelMC complexes presented on an AP, and it would
be interestig to detennne the relative number of peptide/class II MHC complexes on 
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following antigen given Lv., Lp., or s.c. in adjuvant. Also, because IL- IO has been
shown to downrgulate Th1 responses (63), detection of this cytokine following in vitro
IIIII
stimulation of T cells from the treated anmas would provide an explanation for the reduced
proliferative responses and the Th1 cytokines observed in animals given low doses of
antigen. In adtion, Th cells have been implicated in the suppression ofTh1 responses
(80); therefore it might be wortwhile to tr to generte Th 1 and Th2 clones frm the
treated anims and then determe how they would afect a response to an imunogenic
challenge when injected i.v. into syngeneic recipients.
Addtional questions also remai regarding the lack of tolerace to a trsgenic self
antigen observed in the C57BL/6 str. Is tolerance induced by negative selection in the
high affity T cells, while the low afmity T cells escape deletion? This could be examed
in the F1-nontrsgenic and trsgenic anmas using an antiboy to MHC class II to block
the proliferative response to antigen. If the response observed in the nontransgenic 
anmas
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is mostly due to high afnity T cells and in the trsgenic animals it is due to low afity T
cells, then more antiboy would be required to block the T cell proliferative response frm
the nontrsgenic animals than frm the trsgenic anims. There is also evidence in the
literatu that C57BU6 mice caot present an imunodomiant detennnant ofHE, 46-
61, beause they are unable to cleave the argiine residue found at position 61, an event
which would enable the I- MHC molecules to bind this detennnant (118). However,
C3H.SW mice that possess identical MHC molecules as the C57BU6 mice ar able 
cleave HE from 46-61 to 46-60 and therefore respond to this detennnant. It would be
:!ilhdi
'lllillli'
interesting to breed transgenic C57BU6 mice to C3H.SW mice and test the proliferative
responses of theF1-trsgenic anmas to detere whether the presence of a high affmity
Iill
::1111
dominant detennnant of HE would result in more effcient tolerace induction. ll,
II,
1111
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